<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37921381</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2173-9110</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><PubDate><Year>2023</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>Revista espanola de salud publica</Title><ISOAbbreviation>Rev Esp Salud Publica</ISOAbbreviation></Journal><ArticleTitle>[Impacto de la dependencia funcional de los pacientes mayores atendidos en los servicios de Urgencias espa&#xf1;oles durante la primera ola pand&#xe9;mica de la COVID-19 sobre la mortalidad a 30, 180 y 365 d&#xed;as en funci&#xf3;n del diagn&#xf3;stico (COVID versus no COVID).].</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e202310085</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Functional assessment is part of geriatric assessment. How it is performed in hospital Emergency Departments (ED) is poorly understood, let alone its prognostic value. The aim of this paper was to investigate whether baseline disability to perform basic activities of daily living (BADL) was an independent prognostic factor for death after the index visit to the ED during the first wave of the COVID-19 pandemic and whether it had a different impact on patients with and without diagnosis of COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective observational study of the EDEN-Covid (Emergency Department and Elder Needs during COVID) cohort was carried out, consisting of all patients aged &#x2265;65 years seen in 52 Spanish EDs selected by chance during 7 consecutive days (30/3/2020 to 5/4/2020). Demographic, clinical, functional, mental and social variables were analyzed. Dependence was categorized with the Barthel index (BI) as independent (BI=100), mild-moderate dependence (100&gt;BI&gt;60) and severe-total dependence (BI&lt;60), and their crude and adjusted association was evaluated with mortality at 30, 180 and 365 days using COX proportional hazards models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 9,770 enrolled patients with a mean age of 79 years, 51% were men, 6,305 (64.53%) were independent, 2,340 (24%) had mild-moderate dependence, and 1,125 (11.5%) severe-total dependence. The number of deaths at 30 days in these three groups was 500 (7.9%), 521 (22.3%) and 378 (33.6%), respectively; at 180 days it was 757 (12%), 725 (30.9%) and 526 (46.8%); and at 365 days 954 (15.1%), 891 (38.1%) and 611 (54.3%). In relation to independent patients, the adjusted risks (hazard ratio) of dying within 30 days associated with mild-moderate and severe-total dependency were 1.91 (95% CI: 1.66-2.19) and 2.51. (2.11-2.98); at 180 days they were 1.88 (1.68-2.11) and 2.64 (2.28-3.05); and at 365 days they were 1.82 (1.64-2.02) and 2.47 (2.17-2.82). This negative impact of dependency on mortality was greater in patients diagnosed with COVID-19 than in non-COVID-19 (p interaction at 30, 180 and 365 days of 0.36, 0.05 and 0.04).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The functional dependence of older patients who attend Spanish EDs during the first wave of the pandemic is associated with mortality at 30, 180 and 365 days, and this risk is significantly higher in patients treated for COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez Alonso</LastName><ForeName>Ces&#xe1;reo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Cl&#xed;nico San Carlos. IDISSC. Universidad Complutense. Madrid. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuentes Ferrer</LastName><ForeName>Manuel E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n; Hospital Universitario Nuestra Se&#xf1;ora de Candelaria. Santa Cruz de Tenerife. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Lamberechts</LastName><ForeName>Eric Jorge</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Cl&#xed;nico San Carlos. IDISSC. Universidad Complutense. Madrid. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguil&#xf3; Mir</LastName><ForeName>Sira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>&#xc1;rea de Urgencias; Hospital Cl&#xed;nic. IDIBAPS. Universitat de Barcelona. Barcelona. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez</LastName><ForeName>S&#xf2;nia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>&#xc1;rea de Urgencias; Hospital Cl&#xed;nic. IDIBAPS. Universitat de Barcelona. Barcelona. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacob Rodriguez</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Universitari de Bellvitge. L'Hospitalet de Llobregat (Barcelona). Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pi&#xf1;era Salmer&#xf3;n</LastName><ForeName>Pascual</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Reina Sof&#xed;a. Murcia. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil-Rodrigo</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Unidad de Estancia Corta y Hospitalizaci&#xf3;n a Domicilio; Hospital Doctor Balmis de Alicante. Instituto de Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de Alicante (ISABIAL); Universidad Miguel Hern&#xe1;ndez. Alicante. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llorens</LastName><ForeName>Pere</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Unidad de Estancia Corta y Hospitalizaci&#xf3;n a Domicilio; Hospital Doctor Balmis de Alicante. Instituto de Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de Alicante (ISABIAL); Universidad Miguel Hern&#xe1;ndez. Alicante. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burillo-Putze</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Facultad de Ciencias de la Salud; Universidad Europea de Canarias. Santa Cruz de Tenerife. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montero P&#xe9;rez</LastName><ForeName>Francisco Javier</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Reina Sof&#xed;a. C&#xf3;rdoba. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alquezar-Arb&#xe9;</LastName><ForeName>Aitor</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital de la Santa Creu i Sant Pau. Barcelona. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xed;os Gallardo</LastName><ForeName>Rafaela</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Virgen del Roc&#xed;o. Sevilla. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berenguer Diez</LastName><ForeName>Mar&#xed;a Amparo</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital General Universitario Dr. Peset. Valencia. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Truyol M&#xe1;s</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Universitario Son Espases. Palma de Mallorca. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Laguna</LastName><ForeName>Nieves</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Cl&#xed;nica Universitaria Navarra. Madrid. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cort&#xe9;s Soler</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Cl&#xed;nico Universitario. Valencia. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez Nespereira</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital &#xc1;lvaro Cunqueiro. Vigo. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a Garc&#xed;a</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Universitario de Salamanca. Salamanca. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezponda</LastName><ForeName>Patxi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital de Zum&#xe1;rraga.Zum&#xe1;rraga. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez Lorenzo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Virxe da Xunqueira. A Coru&#xf1;a. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortega Liarte</LastName><ForeName>Juan Vicente</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Universitario los Arcos del Mar Menor. Murcia. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos Mart&#xed;n</LastName><ForeName>Jos&#xe9; Mar&#xed;a</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Juan Ram&#xf3;n Jim&#xe9;nez. Huelva. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrero Puente</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Central de Asturias. Oviedo. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melcon Villalibre</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Cl&#xed;nico San Carlos. IDISSC. Universidad Complutense. Madrid. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez Del Castillo</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias; Hospital Cl&#xed;nico San Carlos. IDISSC. Universidad Complutense. Madrid. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mir&#xf3;</LastName><ForeName>&#xd2;scar</ForeName><Initials>&#xd2;</Initials><AffiliationInfo><Affiliation>&#xc1;rea de Urgencias; Hospital Cl&#xed;nic. IDIBAPS. Universitat de Barcelona. Barcelona. Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Impact of functional dependency of elderly patients seen in Spanish emergency departments during the first wave of the COVID-19 pandemic on mortality at 30, 180 and 365 days depending on the diagnosis (COVID versus non-COVID).</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Salud Publica</MedlineTA><NlmUniqueID>9600212</NlmUniqueID><ISSNLinking>1135-5727</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="Y">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">La valoraci&#xf3;n funcional forma parte de la valoraci&#xf3;n geri&#xe1;trica. No se conoce bien c&#xf3;mo se realiza en los servicios de Urgencias hospitalarios (SUH) y menos a&#xfa;n su valor pron&#xf3;stico. El objetivo de este trabajo fue investigar si la dependencia funcional basal para realizar las actividades b&#xe1;sicas de la vida diaria (ABVD) era un factor pron&#xf3;stico independiente de muerte tras la visita &#xed;ndice al SUH durante la primera ola pand&#xe9;mica de la COVID-19 y si tuvo un impacto diferente en pacientes con y sin diagn&#xf3;stico de COVID-19.</AbstractText><AbstractText Label="METODOS" NlmCategory="METHODS">Se realiz&#xf3; un estudio observacional retrospectivo de la cohorte EDEN-Covid (Emergency Department and Elder Needs during COVID) formada por todos los pacientes de edad mayor o igual a 65 a&#xf1;os atendidos en 52 SUH espa&#xf1;oles, seleccionados por oportunidad durante siete d&#xed;as consecutivos (del 30 de marzo al 5 de abril de 2020). Se analizaron variables demogr&#xe1;ficas, cl&#xed;nicas, funcionales, mentales y sociales. La dependencia se categoriz&#xf3; con el &#xed;ndice de Barthel (IB) en independiente (IB=100), dependencia leve-moderada (100&gt;IB&gt;60) y dependencia grave-total (IB&lt;60), y se evalu&#xf3; su asociaci&#xf3;n cruda y ajustada con la mortalidad a 30, 180 y 365 d&#xed;as mediante modelos de riesgos proporcionales de COX.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">De 9.770 pacientes incluidos con una media de edad de 79 a&#xf1;os, un 51% eran hombres, 6.305 (64,53%) eran independientes, 2.340 (24%) ten&#xed;an dependencia leve-moderada y 1.125 (11,5%) dependencia grave-total. El n&#xfa;mero de fallecidos a 30 d&#xed;as en estos tres grupos fue 500 (7,9%), 521 (22,3%) y 378 (33,6%), respectivamente; a 180 d&#xed;as fue 757 (12%), 725 (30,9%) y 526 (46,8%); y a 365 d&#xed;as 954 (15,1%), 891 (38,1%) y 611 (54,3%). En relaci&#xf3;n a los pacientes independientes, los riesgos (hazard ratio) ajustados de fallecer a 30 d&#xed;as, asociados a dependencia leve-moderada y grave-total, fueron 1,91 (IC 95%: 1,66-2,19) y 2,51 (2,11-2,98); a 180 d&#xed;as fueron de 1,88 (1,68-2,11) y 2,64 (2,28-3,05); y a 365 d&#xed;as fueron 1,82 (1,64-2,02) y 2,47 (2,17-2,82). Este impacto negativo de la dependencia sobre la mortalidad fue mayor en pacientes diagnosticados de COVID-19 que en los no COVID-19 (p interacci&#xf3;n a 30, 180 y 365 d&#xed;as de 0,36, 0,05 y 0,04).</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">La dependencia funcional de los pacientes mayores que acuden a SUH espa&#xf1;oles durante la primera ola pand&#xe9;mica se asocia a mortalidad a 30, 180 y 365 d&#xed;as, y este riesgo es significativamente mayor en los pacientes atendidos por COVID-19.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">First wave of the pandemic</Keyword><Keyword MajorTopicYN="N">Functional dependence</Keyword><Keyword MajorTopicYN="N">Hospital Emergencies</Keyword><Keyword MajorTopicYN="N">Mortality at 30, 180 and 365 days</Keyword></KeywordList><CoiStatement>Los autores declaran que no existe ning&#xfa;n conflicto de intereses.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>8</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37921381</ArticleId><ArticleId IdType="pmc">PMC11567071</ArticleId><ArticleId IdType="pii">e202310085</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aminzadeh F, Dalziel WB. Older adults in the emergency department: A systematic review of patterns of use, adverse outcomes, and effectiveness of interventions. Annals of Emergency Medicine 2002;39:238-247.</Citation><ArticleIdList><ArticleId IdType="pubmed">11867975</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminzadeh F, Dalziel WB. Older adults in the emergency department: A systematic review of patterns of use, adverse outcomes, and effectiveness of interventions. Annals of Emergency Medicine. 2002;39:238&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">11867975</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez Alonso C, Mart&#xed;n-S&#xe1;nchez FJ. Geriatric assessment in frail older patients in the emergency department. Reviews in Clinical Gerontology 2013; 23: 275-282.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez Alonso C, Mart&#xed;n-S&#xe1;nchez FJ. Geriatric assessment in frail older patients in the emergency department. Reviews in Clinical Gerontology. 2013;23:275&#x2013;282.</Citation></Reference><Reference><Citation>Mart&#xed;n-S&#xe1;nchez FJ, Fern&#xe1;ndez Alonso C, Gil P. Puntos clave en la asistencia al paciente fr&#xe1;gil en Urgencias. Med Clin (Barc). 2013;140:24-29.</Citation><ArticleIdList><ArticleId IdType="pubmed">22672966</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-S&#xe1;nchez FJ, Fern&#xe1;ndez Alonso C, Gil P. Puntos clave en la asistencia al paciente fr&#xe1;gil en Urgencias. Med Clin. 2013;140:24&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">22672966</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-S&#xe1;nchez FJ, Fern&#xe1;ndez Alonso C, Merino Rubio C. El paciente geri&#xe1;trico en Urgencias. An Sist Sanit Navar. 2010;33(supl.1):163-172.</Citation><ArticleIdList><ArticleId IdType="pubmed">20508687</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-S&#xe1;nchez FJ, Fern&#xe1;ndez Alonso C, Merino Rubio C. El paciente geri&#xe1;trico en Urgencias. An Sist Sanit Navar. 2010;33(supl.1):163&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">20508687</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez Alonso C, Fuentes Ferrer ME, Jim&#xe9;nez Santana MI, Fern&#xe1;ndez Hern&#xe1;ndez L, de la Cruz Garc&#xed;a M, Gonz&#xe1;lez del Castillo J et al. Intervenci&#xf3;n multidimensional que mejora el pron&#xf3;stico a corto plazo entre los ancianos fr&#xe1;giles dados de alta desde una unidad de corta estancia: estudio cuasiexperimental. Revista Cl&#xed;nica espa&#xf1;ola 2018; 4:163-169.</Citation><ArticleIdList><ArticleId IdType="pubmed">29499984</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez Alonso C, Fuentes Ferrer ME, Jim&#xe9;nez Santana MI, Fern&#xe1;ndez Hern&#xe1;ndez L, de la Cruz Garc&#xed;a M, Gonz&#xe1;lez del Castillo J. Intervenci&#xf3;n multidimensional que mejora el pron&#xf3;stico a corto plazo entre los ancianos fr&#xe1;giles dados de alta desde una unidad de corta estancia: estudio cuasiexperimental. Revista Cl&#xed;nica espa&#xf1;ola. 2018;4:163&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">29499984</ArticleId></ArticleIdList></Reference><Reference><Citation>Mooijaart SP, Lucke JA, Brabrand M, Conroy S, Nickel CH. Geriatric emergency medicine: time for a new approach on a European level. Eur J Emerg Med. 2019; 26:75-76.</Citation><ArticleIdList><ArticleId IdType="pubmed">30801429</ArticleId></ArticleIdList></Reference><Reference><Citation>Mooijaart SP, Lucke JA, Brabrand M, Conroy S, Nickel CH. Geriatric emergency medicine: time for a new approach on a European level. Eur J Emerg Med. 2019;26:75&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">30801429</ArticleId></ArticleIdList></Reference><Reference><Citation>Cid-Ruzafa J, Dami&#xe1;n-Moreno J. Valoraci&#xf3;n de la discapacidad f&#xed;sica: el &#xed;ndice de Barthel. Rev Esp Salud P&#xfa;blica 1997; 71: 127-137.</Citation><ArticleIdList><ArticleId IdType="pubmed">9546856</ArticleId></ArticleIdList></Reference><Reference><Citation>Cid-Ruzafa J, Dami&#xe1;n-Moreno J. Valoraci&#xf3;n de la discapacidad f&#xed;sica: el &#xed;ndice de Barthel. Rev Esp Salud P&#xfa;blica. 1997;71:127&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">9546856</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez Alonso C, Mart&#xed;n S&#xe1;nchez FJ, Fuentes Ferrer M, Gonz&#xe1;lez del Castillo J, Verdejo Bravo C, Gil Gregorio P et al. Valor Pron&#xf3;stico de la Valoraci&#xf3;n Funcional al Ingreso en una Unidad de Corta Estancia de Urgencias. Rev Esp Geriatr Gerontol 2010; 45: 63-66.</Citation><ArticleIdList><ArticleId IdType="pubmed">20181412</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez Alonso C, Mart&#xed;n S&#xe1;nchez FJ, Fuentes Ferrer M, Gonz&#xe1;lez del Castillo J, Verdejo Bravo C, Gregorio P. Valor Pron&#xf3;stico de la Valoraci&#xf3;n Funcional al Ingreso en una Unidad de Corta Estancia de Urgencias. Rev Esp Geriatr Gerontol. 2010;45:63&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">20181412</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-M&#xe9;ndez C, D&#xed;ez-Villanueva P, Bonanad C, Ort&#xed;z-Cortes C, Barge-Caballero E, Goirigolzarri J et al. Fragilidad y pron&#xf3;stico de los pacientes mayores con insuficiencia cardiaca. Med Clin 2022; 75: 1011-1019.</Citation></Reference><Reference><Citation>Jim&#xe9;nez-M&#xe9;ndez C, D&#xed;ez-Villanueva P, Bonanad C, Ort&#xed;z-Cortes C, Barge-Caballero E, Goirigolzarri J. Fragilidad y pron&#xf3;stico de los pacientes mayores con insuficiencia cardiaca. Med Clin. 2022;75:1011&#x2013;1019.</Citation></Reference><Reference><Citation>Puig-Campmany M, Ris Romeu J. El anciano fr&#xe1;gil en Urgencias: principales retos. Emergencias. 2022;34:415-417.</Citation><ArticleIdList><ArticleId IdType="pubmed">36625690</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig-Campmany M, Ris Romeu J. El anciano fr&#xe1;gil en Urgencias: principales retos. Emergencias. 2022;34:415&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">36625690</ArticleId></ArticleIdList></Reference><Reference><Citation>Escudero-Acha P, Leizaola O, L&#xe1;zaro N, Cordero M, Coss&#xed;o AM, Ballesteros D et al. Estudio ADENI-UCI: An&#xe1;lisis de las decisiones de no ingreso en UCI como medida de limitaci&#xf3;n de los tratamientos de soporte vital. Medicina Intensiva 2022; 46: 192-200.</Citation><ArticleIdList><ArticleId IdType="pubmed">33386143</ArticleId></ArticleIdList></Reference><Reference><Citation>Escudero-Acha P, Leizaola O, L&#xe1;zaro N, Cordero M, Coss&#xed;o AM, Ballesteros D. Estudio ADENI-UCI: An&#xe1;lisis de las decisiones de no ingreso en UCI como medida de limitaci&#xf3;n de los tratamientos de soporte vital. Medicina Intensiva. 2022;46:192&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">33386143</ArticleId></ArticleIdList></Reference><Reference><Citation>Centro de Coordinaci&#xf3;n de Alertas y Emergencias Sanitarias Actualizaci&#xf3;n n&#xba; 624. Enfermedad por el coronavirus (COVID-19). 12.08.2022. (Consultado 15 Agosto 2022). Disponible en: https:// www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Actualizacion_624_COVID-19.pdf</Citation></Reference><Reference><Citation>Centro de Coordinaci&#xf3;n de Alertas y Emergencias Sanitarias   [12-08-2022];2022  
 https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Actualizacion_624_COVID-19.pdf
.</Citation></Reference><Reference><Citation>Mir&#xf3; O, Gonz&#xe1;lez Del Castillo J. Red de investigaci&#xf3;n SIESTA: memoria de resultados de su primer reto investigador (reto COVID-19). Emergencias. 2022; 34:225-227.</Citation><ArticleIdList><ArticleId IdType="pubmed">35736529</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir&#xf3; O, Gonz&#xe1;lez Del Castillo J. Red de investigaci&#xf3;n SIESTA: memoria de resultados de su primer reto investigador (reto COVID-19). Emergencias. 2022;34:225&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">35736529</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-S&#xe1;nchez FJ, Bermejo Boixareu C. EDEN: una oportunidad para conocer y mejorar la atenci&#xf3;n integral de las personas mayores en los servicios de urgencias espa&#xf1;oles. Emergencias. 2022; 34:409-410.</Citation><ArticleIdList><ArticleId IdType="pubmed">36625687</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-S&#xe1;nchez FJ, Bermejo Boixareu C. EDEN: una oportunidad para conocer y mejorar la atenci&#xf3;n integral de las personas mayores en los servicios de urgencias espa&#xf1;oles. Emergencias. 2022;39:409&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">36625687</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir&#xf3; O, Jacob J, Garc&#xed;a-Lamberechts EJ, Pi&#xf1;era Salmer&#xf3;n P, Llorens P, Jim&#xe9;nez S et al. Caracter&#xed;sticas sociodemogr&#xe1;ficas, funcionales y consumo de recursos de la poblaci&#xf3;n mayor atendida en los servicios de urgencias espa&#xf1;oles: una aproximaci&#xf3;n desde la cohorte EDEN. Emergencias. 2022; 34:418-427.</Citation><ArticleIdList><ArticleId IdType="pubmed">36625691</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir&#xf3; O, Jacob J, Garc&#xed;a-Lamberechts EJ, Pi&#xf1;era Salmer&#xf3;n P, Llorens P, Jim&#xe9;nez S. Caracter&#xed;sticas sociodemogr&#xe1;ficas, funcionales y consumo de recursos de la poblaci&#xf3;n mayor atendida en los servicios de urgencias espa&#xf1;oles: una aproximaci&#xf3;n desde la cohorte EDEN. Emergencias. 2022;34:418&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pubmed">36625691</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez Del Castillo J, Jacob J, Garc&#xed;a-Lamberechts EJ, Pi&#xf1;era Salmer&#xf3;n P, Alqu&#xe9;zar-Arb&#xe9; A, Llorens P et al. Sociodemograf&#xed;a, comorbilidad y situaci&#xf3;n funcional basal de los pacientes mayores atendidos en urgencias durante la pandemia de COVID y su relaci&#xf3;n con la mortalidad: an&#xe1;lisis a partir de la cohorte EDEN-COVID. Emergencias. 2022;34:428-436.</Citation><ArticleIdList><ArticleId IdType="pubmed">36625692</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez Del Castillo O, Jacob J, Garc&#xed;a-Lamberechts EJ, Pi&#xf1;era Salmer&#xf3;n P, Alqu&#xe9;zar-Arb&#xe9; A, Llorens P. Sociodemograf&#xed;a, comorbilidad y situaci&#xf3;n funcional basal de los pacientes mayores atendidos en urgencias durante la pandemia de COVID y su relaci&#xf3;n con la mortalidad: an&#xe1;lisis a partir de la cohorte EDEN-COVID. Emergencias. 2022;34:428&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">36625692</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373-383.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Anuncio de cambio y nueva normativa para la codificaci&#xf3;n de la infecci&#xf3;n por SARS-CoV-2 (COVID-19). Unidad T&#xe9;cnica de Codificaci&#xf3;n CIE-10-ES. Subdirecci&#xf3;n general de Informaci&#xf3;n sanitaria. Gobierno de Espa&#xf1;a. Disponible en: https://www.sanidad.gob.es/estadEstudios/estadisticas/normalizacion/CIE10/Norm_COVID19_01072020.pdf</Citation></Reference><Reference><Citation>Unidad T&#xe9;cnica de Codificaci&#xf3;n CIE-10-ES. Subdirecci&#xf3;n general de Informaci&#xf3;n sanitaria. Gobierno de Espa&#xf1;a   
 https://www.sanidad.gob.es/estadEstudios/estadisticas/normalizacion/CIE10/Norm_COVID19_01072020.pdf
.</Citation></Reference><Reference><Citation>Instituto de Salud Carlos III. Vigilancia de los excesos de mortalidad por todas las causas. MoMo. Situaci&#xf3;n a 06 de abril de 2020. (Consultado 17 Agosto 2022). Disponible en: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/ EnfermedadesTransmisibles/MoMo/Documents/informesMoMo2020/MoMo_Situacion%20a%206%20de%20abril_CNE.pdf</Citation></Reference><Reference><Citation>Instituto de Salud Carlos III   [17-08-2022]; 
 https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/MoMo/Documents/informesMoMo2020/MoMo_Situacion%20a%206%20de%20abril_CNE.pdf
.</Citation></Reference><Reference><Citation>Mart&#xed;n-S&#xe1;nchez FJ, Gonz&#xe1;lez Del Castillo J, Valls Carb&#xf3; A, L&#xf3;pez Picado A, Mart&#xed;nez-Valero C, Miranda JD et al. Categor&#xed;as diagn&#xf3;sticas y resultados a corto plazo en los pacientes con sospecha de COVID-19 atendidos en un servicio de Urgencias. Emergencias. 2020;32:242-252.</Citation><ArticleIdList><ArticleId IdType="pubmed">32692001</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-S&#xe1;nchez FJ, Gonz&#xe1;lez Del Castillo J, Valls Carb&#xf3; A, L&#xf3;pez Picado A, Mart&#xed;nez-Valero C, Miranda JD. Categor&#xed;as diagn&#xf3;sticas y resultados a corto plazo en los pacientes con sospecha de COVID-19 atendidos en un servicio de Urgencias. Emergencias. 2020;32:242&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">32692001</ArticleId></ArticleIdList></Reference><Reference><Citation>Laosa O, Pedraza L, &#xc1;lvarez-Bustos A, Carnicero JA, Rodriguez-Artalejo F, Rodriguez-Ma&#xf1;as L. Rapid assessment at hospital admission of mortality risk from COVID-19: The role of functional status. J Am Med Dir Assoc. 2020;21(12):1798-1802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543696</ArticleId><ArticleId IdType="pubmed">33160872</ArticleId></ArticleIdList></Reference><Reference><Citation>Laosa O, Pedraza L, &#xc1;lvarez-Bustos A, Carnicero JA, Rodriguez-Artalejo F, Rodriguez-Ma&#xf1;as L. Rapid assessment at hospital admission of mortality risk from COVID-19: The role of functional status. J Am Med Dir Assoc. 2020;21(12):1798&#x2013;1802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543696</ArticleId><ArticleId IdType="pubmed">33160872</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotnikov G, Waizman E, Tzur I, Yusupov A, Shapira Y, Gorelik O. The prognostic role of functional dependency in older inpatients with COVID-19. BMC Geriatrics 2021; 21:219</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011046</ArticleId><ArticleId IdType="pubmed">33789578</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotnikov G, Waizman E, Tzur I, Yusupov A, Shapira Y, Gorelik O. The prognostic role of functional dependency in older inpatients with COVID-19. BMC Geriatrics. 2021;21:219&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011046</ArticleId><ArticleId IdType="pubmed">33789578</ArticleId></ArticleIdList></Reference><Reference><Citation>Fresco L, Osorio G, Carb&#xf3; M, Marco DN, Garc&#xed;a-Gozalbes J, Artajona et al. Validaci&#xf3;n temporal de un modelo de riesgo de mortalidad por COVID-19 en una cohorte prospectiva en un servicio de Urgencias de un hospital de tercer nivel. Emergencias. 2022;34:196-203</Citation><ArticleIdList><ArticleId IdType="pubmed">35736524</ArticleId></ArticleIdList></Reference><Reference><Citation>Fresco L, Osorio G, Carb&#xf3; M, Marco DN, Garc&#xed;a-Gozalbes J, Artajona Validaci&#xf3;n temporal de un modelo de riesgo de mortalidad por COVID-19 en una cohorte prospectiva en un servicio de Urgencias de un hospital de tercer nivel. Emergencias. 2022;34:196&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">35736524</ArticleId></ArticleIdList></Reference><Reference><Citation>Luca Novelli L, Raimondi F, Carioli G, Carobbio A, Pappacena S, Biza R et al. One-year mortality in COVID-19 is associated with patients&#x2019; comorbidities rather than pneumonia severity. Respir Med Res 2022;83:100976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9691276</ArticleId><ArticleId IdType="pubmed">36473331</ArticleId></ArticleIdList></Reference><Reference><Citation>Luca Novelli L, Raimondi F, Carioli G, Carobbio A, Pappacena S, Biza R. One-year mortality in COVID-19 is associated with patients&#x2019; comorbidities rather than pneumonia severity. Respir Med Res. 2022;83:100976&#x2013;100976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9691276</ArticleId><ArticleId IdType="pubmed">36473331</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidoriki I, Frountzas M, Schizas D. Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly? Med Hypotheses 2020;144:109946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264929</ArticleId><ArticleId IdType="pubmed">32512494</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidoriki I, Frountzas M, Schizas D. Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly? Med Hypotheses. 2020;144:109946&#x2013;109946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264929</ArticleId><ArticleId IdType="pubmed">32512494</ArticleId></ArticleIdList></Reference><Reference><Citation>Pant P, Joshi A, Basnet B, Shrestha BM, Bista NR, Bam N, Das SK. Prevalence of Functional Limitation in COVID-19 Recovered Patients Using the Post COVID-19 Functional Status Scale. JNMA J Nepal Med Assoc. 2021;59:7-11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893391</ArticleId><ArticleId IdType="pubmed">34508442</ArticleId></ArticleIdList></Reference><Reference><Citation>Pant P, Joshi A, Basnet B, Shrestha BM, Bista NR, Bam N, Das SK. Prevalence of Functional Limitation in COVID-19 Recovered Patients Using the Post COVID-19 Functional Status Scale. JNMA J Nepal Med Assoc. 2021;59:7&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893391</ArticleId><ArticleId IdType="pubmed">34508442</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateo Rodr&#xed;guez E, Puchades Gimeno F, Ezzeddine Angulo A, Asensio Samper J, Saiz Ruiz C, L&#xf3;pez Alarc&#xf3;n MD. S&#xed;ndrome post cuidados intensivos en COVID-19. Estudio piloto unic&#xe9;ntrico. La calma no llega tras la tempestad. Med Clin 2022; 159: 321-326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8723835</ArticleId><ArticleId IdType="pubmed">35123806</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateo Rodr&#xed;guez E, Puchades Gimeno F, Ezzeddine Angulo A, Asensio Samper J, Saiz Ruiz C, L&#xf3;pez Alarc&#xf3;n MD. S&#xed;ndrome post cuidados intensivos en COVID-19. Estudio piloto unic&#xe9;ntrico. La calma no llega tras la tempestad. Med Clin. 2022;159:321&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8723835</ArticleId><ArticleId IdType="pubmed">35123806</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfa;&#xf1;ez-Gil IJ, Estrada V, Fern&#xe1;ndez-P&#xe9;rez C, Fern&#xe1;ndez-Rozas I, Mart&#xed;n-S&#xe1;nchez FJ, Macaya C. Curva pand&#xe9;mica COVID-19, sobrecarga sanitaria y mortalidad. Emergencias. 2020;32:293-295.</Citation><ArticleIdList><ArticleId IdType="pubmed">32692012</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfa;&#xf1;ez-Gil IJ, Estrada V, Fern&#xe1;ndez-P&#xe9;rez C, Fern&#xe1;ndez-Rozas I, Mart&#xed;n-S&#xe1;nchez FJ, Macaya C. Curva pand&#xe9;mica COVID-19, sobrecarga sanitaria y mortalidad. Emergencias. 2020;32:293&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">32692012</ArticleId></ArticleIdList></Reference><Reference><Citation>Afonso-Argil&#xe9;s FJ, Comas Serrano M, Bl&#xe1;zquez Andi&#xf3;n M, Castells Oliveres X, Cirera Lorenzo I, Garc&#xed;a P&#xe9;rez D et al. Factores asociados con mortalidad a corto plazo en personas que viven en residencias atendidas en servicios de urgencias: resultados del estudio multic&#xe9;ntrico Caregency. Emergencias. 2022; 34:437-443.</Citation><ArticleIdList><ArticleId IdType="pubmed">36625693</ArticleId></ArticleIdList></Reference><Reference><Citation>Afonso-Argil&#xe9;s FJ, Comas Serrano M, Bl&#xe1;zquez Andi&#xf3;n M, Castells Oliveres X, Cirera Lorenzo I, Garc&#xed;a P&#xe9;rez D. Factores asociados con mortalidad a corto plazo en personas que viven en residencias atendidas en servicios de urgencias: resultados del estudio multic&#xe9;ntrico Caregency. Emergencias. 2022;34:437&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">36625693</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-S&#xe1;nchez FJ, Perdigones J, Ferr&#xe9; Losa C, Llopis F, Navarro Bustos C, Borraz Ordas C et al. Modelo de riesgo de mortalidad a 180 d&#xed;as en los pacientes ancianos ingresados en unidades de corta estancia: 6M UCE-SCORE. Emergencias. 2018;30:315-320.</Citation><ArticleIdList><ArticleId IdType="pubmed">30260115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-S&#xe1;nchez FJ, Perdigones J, Llopis C, Navarro Bustos C, Borraz Ordas C. Modelo de riesgo de mortalidad a 180 d&#xed;as en los pacientes ancianos ingresados en unidades de corta estancia: 6M UCE-SCORE. Emergencias. 2018;30:315&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pubmed">30260115</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Manglano J, G&#xf3;mez-Aguirre N, Velilla-Marco J, Lamb&#xe1;n Aranda MP, de Escalante Yang&#xfc;ela B, Fuertes Ruiz D, en nombre de los investigadores del estudio PALIARAGON.Comparison between PROFUND and PALIAR indexes in polypathological patients with advanced non-oncologic chronic diseases. Med Clin 2019;153(5):196-201.</Citation><ArticleIdList><ArticleId IdType="pubmed">30928153</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Manglano J, G&#xf3;mez-Aguirre N, Velilla-Marco J, Lamb&#xe1;n Aranda MP, de Escalante Yang&#xfc;ela B, Fuertes Ruiz D. Comparison between PROFUND and PALIAR indexes in polypathological patients with advanced non-oncologic chronic diseases. Med Clin. 2019;153(5):196&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">30928153</ArticleId></ArticleIdList></Reference><Reference><Citation>Magidson PD, Carpenter CR. Trends in Geriatric Emergency Medicine. Emergency Medicine Clinics of North America 2021;39:243-255.</Citation><ArticleIdList><ArticleId IdType="pubmed">33863457</ArticleId></ArticleIdList></Reference><Reference><Citation>Magidson PD, Carpenter CR. Trends in Geriatric Emergency Medicine. Emergency Medicine Clinics of North America. 2021;39:243&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">33863457</ArticleId></ArticleIdList></Reference><Reference><Citation>Pola Ferr&#xe1;ndez E, Zuza Santacilia I, Gil Ta rragato S, Justo Gil S, Campos Esteban P, L&#xf3;pez Franco MA. Promoci&#xf3;n del envejecimiento saludable a trav&#xe9;s del abordaje de la fragilidad. Rev Esp Salud P&#xfa;blica. 2021; 95: 4 de junio e202106095.</Citation><ArticleIdList><ArticleId IdType="pubmed">34620823</ArticleId></ArticleIdList></Reference><Reference><Citation>Pola Ferr&#xe1;ndez E, Zuza Santacilia I, Gil Ta rragato S, Justo Gil S, Campos Esteban P, L&#xf3;pez Franco MA. Promoci&#xf3;n del envejecimiento saludable a trav&#xe9;s del abordaje de la fragilidad. Rev Esp Salud P&#xfa;blica. 2021;95:e202106095&#x2013;e202106095.</Citation><ArticleIdList><ArticleId IdType="pubmed">34620823</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35736525</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2386-5857</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title><ISOAbbreviation>Emergencias</ISOAbbreviation></Journal><ArticleTitle>Efficiency of screening for human immunodeficiency virus infection in emergency departments: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>204</StartPage><EndPage>212</EndPage><MedlinePgn>204-212</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES">The rates of undiagnosed and late-diagnosed human immunodeficiency virus (HIV) infection are high. Screening for HIV infection in hospital emergency departments (EDs) could offer a way to increase the number of diagnoses. Our aim was to analyze whether universal hospital ED screening for HIV is efficient.</AbstractText><AbstractText Label="MATERIAL AND METHODS">We followed the guidelines for Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). PubMed, the Cochrane Library, LILACS, Scopus, EMBASE, and the Web of Science were searched using the following terms: "HIV infections/epidemiology," "AIDS serodiagnosis," "emergency service, hospital," "prevalence," and "mass screening/methods." The searches were limited to a 5-year time frame (2016-2020); only publications in English or Spanish were collected. We included studies of universal HIV screening among hospital ED patients and evaluated them using the Quality Assessment Tool for Quantitative Studies.</AbstractText><AbstractText Label="RESULTS">A total of 273 articles were identified. Twelve met the inclusion criteria. The studies analyzed 103 731 patient samples and yielded 652 new HIV diagnoses. A random effects model estimated an overall new-diagnosis prevalence of 0.60% (95% CI, 0.39%-0.84%). The heterogeneity statistic I2 was high, at 90.02% (P .001). Estimates of prevalence based on studies carried out in Europe, the United States, and Africa were, respectively, 0.48% (95% CI, 0.13%-1.03%), 0.54% (95% CI, 0.33%-0.40%), and 5.6% (95% CI, 3.37%-9.2%). The studies received quality ratings of moderate or strong.</AbstractText><AbstractText Label="CONCLUSION">Although the reviewed studies applied various screening strategies to identify new HIV diagnoses, our findings support the conclusion that universal screening is efficient.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gonz&#xe1;lez Del Castillo</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria, Hospital San Carlos (IdISSC), Madrid, Espa&#xf1;a. Servicio de Urgencias, Hospital Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuentes Ferrer</LastName><ForeName>Manuel Enrique</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Preventiva, Unidad de Apoyo Metodol&#xf3;gicoa la Investigaci&#xf3;n (UAMI), Instituto de Investigaci&#xf3;n Sanitaria del Hospital Cl&#xed;nico San Carlos (IdISSC), Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez P&#xe9;rez</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Preventiva, Complejo Hospitalario Universitario de Santiago de Compostela, A Coru&#xf1;a, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina Romera</LastName><ForeName>Germ&#xe1;n</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Preventiva, Complejo Hospitalario Universitario de Santiago de Compostela, A Coru&#xf1;a, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xfa;&#xf1;ez Orantos</LastName><ForeName>Mar&#xed;a Jos&#xe9;</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna-Infecciosas, Hospital Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estrada P&#xe9;rez</LastName><ForeName>Vicente</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna-Infecciosas, Hospital Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><VernacularTitle>Eficiencia del cribado de VIH en urgencias: revisi&#xf3;n sistem&#xe1;tica y metan&#xe1;lisis.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Emergencias</MedlineTA><NlmUniqueID>9805751</NlmUniqueID><ISSNLinking>1137-6821</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO">Existe una elevada tasa de infecci&#xf3;n oculta y diagn&#xf3;stico tard&#xed;o en el virus de la inmunodeficiencia hu mana (VIH). La realizaci&#xf3;n de pruebas diagn&#xf3;sticas de infecci&#xf3;n por VIH en los servicios de urgencias hospitalarios (SUH) puede representar una oportunidad para aumentar el n&#xfa;mero de diagn&#xf3;sticos. El objetivo de este trabajo es analizar si el cribado universal para el VIH realizado en los SUH es eficiente.</AbstractText><AbstractText Label="METODO">Se realiza una revisi&#xf3;n sistem&#xe1;tica y metan&#xe1;lisis siguiendo la normativa PRISMA en la base de datos de Pubmed, Cochrane, LILACS, Scopus, EMBASE y WOS utilizando una combinaci&#xf3;n de t&#xe9;rminos MESH: &#x201c;HIV Infections/ epidemiology&#x201d;, &#x201c;AIDS Serodiagnosis&#x201d;, &#x201c;Emergency Service, Hospital&#x201d;, &#x201c;Prevalence&#x201d;, &#x201c;Mass screening/methods&#x201d;. Los criterios de la b&#xfa;squeda se centraron en los &#xfa;ltimos 5 a&#xf1;os (2016-2020) y en los art&#xed;culos publicados en ingl&#xe9;s y en espa&#xf1;ol. Se incluyeron los estudios de pruebas de cribado universal mediante test de cribado de VIH realizadas en los SUH. Para evaluar la calidad de los art&#xed;culos se utiliz&#xf3; el cuestionario &#x201c;Quality assessment tool for quantitative studies&#x201d;.</AbstractText><AbstractText Label="RESULTADOS">Se identificaron un total de 273 art&#xed;culos de los cuales se analizaron finalmente 12 que cumpl&#xed;an los criterios de inclusi&#xf3;n. Los estudios incluidos representan un total de 103.731 muestras analizadas obteni&#xe9;ndose un total de 652 nuevos diagn&#xf3;sticos de VIH. La prevalencia conjunta obtenida a trav&#xe9;s del modelo de efectos aleatorios fue de 0,60% (IC 95%: 0,39-0,84) y el valor del I2 revela una presencia elevada de heterogeneidad (I2 90,02%; p 0,001). La prevalencia conjunta en los estudios incluidos realizados en Europa, Am&#xe9;rica y &#xc1;frica fue de 0,48% (IC 95%: 0,13-1,03), 0,54% (IC 95%: 0,33-0,40) y 5,6% (IC 95%: 3,37-9,2), respectivamente. La evaluaci&#xf3;n de la calidad de los estudios fue de moderada a fuerte.</AbstractText><AbstractText Label="CONCLUSIONES">Aunque las pruebas del VIH pueden realizarse utilizando diferentes estrategias, nuestros datos avalan que una estrategia de cribado universal es eficiente.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cribado de VIH.</Keyword><Keyword MajorTopicYN="N">Diagn&#xf3;stico oculto de VIH.</Keyword><Keyword MajorTopicYN="N">Diagn&#xf3;stico tard&#xed;o de VIH.</Keyword><Keyword MajorTopicYN="N">HIV screening.</Keyword><Keyword MajorTopicYN="N">Late HIV diagnosis.</Keyword><Keyword MajorTopicYN="N">Undiagnosed human immunodeficiency virus (HIV) infection.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35736525</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35708486</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>22</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>10</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Novel genes and sex differences in COVID-19 severity.</ArticleTitle><Pagination><StartPage>3789</StartPage><EndPage>3806</EndPage><MedlinePgn>3789-3806</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddac132</ELocationID><Abstract><AbstractText>Here, we describe the results of a genome-wide study conducted in 11&#x2009;939 coronavirus disease 2019 (COVID-19) positive cases with an extensive clinical information that were recruited from 34 hospitals across Spain (SCOURGE consortium). In sex-disaggregated genome-wide association studies for COVID-19 hospitalization, genome-wide significance (P&#x2009;&lt;&#x2009;5&#x2009;&#xd7;&#x2009;10-8) was crossed for variants in 3p21.31 and 21q22.11 loci only among males (P&#x2009;=&#xa0;1.3&#x2009;&#xd7;&#x2009;10-22 and P&#x2009;=&#xa0;8.1&#x2009;&#xd7;&#x2009;10-12, respectively), and for variants in 9q21.32 near TLE1 only among females (P&#x2009;=&#xa0;4.4&#x2009;&#xd7;&#x2009;10-8). In a second phase, results were combined with an independent Spanish cohort (1598 COVID-19 cases and 1068 population controls), revealing in the overall analysis two novel risk loci in 9p13.3 and 19q13.12, with fine-mapping prioritized variants functionally associated with AQP3 (P&#x2009;=&#xa0;2.7&#x2009;&#xd7;&#x2009;10-8) and ARHGAP33 (P&#x2009;=&#xa0;1.3&#x2009;&#xd7;&#x2009;10-8), respectively. The meta-analysis of both phases with four European studies stratified by sex from the Host Genetics Initiative (HGI) confirmed the association of the 3p21.31 and 21q22.11 loci predominantly in males and replicated a recently reported variant in 11p13 (ELF5, P&#x2009;=&#x2009;4.1&#x2009;&#xd7;&#x2009;10-8). Six of the COVID-19 HGI discovered loci were replicated and an HGI-based genetic risk score predicted the severity strata in SCOURGE. We also found more SNP-heritability and larger heritability differences by age (&lt;60 or &#x2265;60&#xa0;years) among males than among females. Parallel genome-wide screening of inbreeding depression in SCOURGE also showed an effect of homozygosity in COVID-19 hospitalization and severity and this effect was stronger among older males. In summary, new candidate genes for COVID-19 severity and evidence supporting genetic disparities among sexes are provided.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cruz</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6964-8898</Identifier><AffiliationInfo><Affiliation>Centro Nacional de Genotipado (CEGEN), Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Singular de Investigaci&#xf3;n en Medicina Molecular y Enfermedades Cr&#xf3;nicas (CIMUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diz-de Almeida</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centro Singular de Investigaci&#xf3;n en Medicina Molecular y Enfermedades Cr&#xf3;nicas (CIMUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez de Heredia</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintela</LastName><ForeName>In&#xe9;s</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centro Nacional de Genotipado (CEGEN), Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceballos</LastName><ForeName>Francisco C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Unidad de Infecci&#xf3;n Viral e Inmunidad, Centro Nacional de Microbiolog&#xed;a (CNM), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pita</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Spanish National Cancer Research Centre, Human Genotyping-CEGEN Unit, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzo-Salazar</LastName><ForeName>Jos&#xe9; M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Genomics Division, Instituto Tecnol&#xf3;gico y de Energ&#xed;as Renovables, 38600 Santa Cruz de Tenerife, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Montelongo</LastName><ForeName>Rafaela</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Genomics Division, Instituto Tecnol&#xf3;gico y de Energ&#xed;as Renovables, 38600 Santa Cruz de Tenerife, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gago-Dom&#xed;nguez</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n P&#xfa;blica Galega de Medicina Xen&#xf3;mica, Sistema Galego de Sa&#xfa;de (SERGAS), 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sevilla Porras</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Gen&#xe9;tica M&#xe9;dica y Molecular (INGEMM), Hospital Universitario La Paz-IDIPAZ, 28046 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tenorio Casta&#xf1;o</LastName><ForeName>Jair Antonio</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Gen&#xe9;tica M&#xe9;dica y Molecular (INGEMM), Hospital Universitario La Paz-IDIPAZ, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ERN-ITHACA-European Reference Network.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nevado</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Gen&#xe9;tica M&#xe9;dica y Molecular (INGEMM), Hospital Universitario La Paz-IDIPAZ, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ERN-ITHACA-European Reference Network.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguado</LastName><ForeName>Jose Mar&#xed;a</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Unit of Infectious Diseases, Hospital Universitario 12 de Octubre, Instituto de Investigaci&#xf3;n Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0002), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Universidad Complutense, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital General Santa B&#xe1;rbara de Soria, 42005 Soria, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilera-Albesa</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pediatric Neurology Unit, Department of Pediatrics, Navarra Health Service Hospital, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Navarra Health Service, NavarraBioMed Research Group, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almadana</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Universitario Virgen Macarena, Neumolog&#xed;a, 41009 Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almoguera</LastName><ForeName>Berta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Genetics &amp; Genomics, Instituto de Investigaci&#xf3;n Sanitaria-Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az University Hospital - Universidad Aut&#xf3;noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez</LastName><ForeName>Nuria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Spanish National Cancer Research Centre, Human Genotyping-CEGEN Unit, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreu-Bernabeu</LastName><ForeName>&#xc1;lvaro</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n (IiSGM), 28007 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Universidad Complutense, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arana-Arri</LastName><ForeName>Eunate</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Biocruces Bizkai HRI, 48903 Barakaldo, Bizkaia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cruces University Hospital, Osakidetza, 48903 Barakaldo, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arango</LastName><ForeName>Celso</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n (IiSGM), 28007 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Mental Health (CIBERSAM), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Universidad Complutense, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arranz</LastName><ForeName>Mar&#xed;a J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Doc&#xe8;ncia I Recerca Mutua Terrassa, 08221 Terrassa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Artiga</LastName><ForeName>Maria-Jesus</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Spanish National Cancer Research Center, CNIO Biobank, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baptista-Rosas</LastName><ForeName>Ra&#xfa;l C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Hospital General de Occidente, 45170 Zapopan, Jalisco, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Universitario de Tonal&#xe1;, Universidad de Guadalajara, 45425 Tonal&#xe1;, Jalisco, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Multidisciplinario en Salud, Universidad de Guadalajara, 45425 Tonal&#xe1;, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barreda-S&#xe1;nchez</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto Murciano de Investigaci&#xf3;n Biosanitaria (IMIB-Arrixaca), 30120 Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Cat&#xf3;lica San Antonio de Murcia (UCAM), 30120 Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belhassen-Garcia</LastName><ForeName>Moncef</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Salamanca-IBSAL, Servicio de Medicina Interna-Unidad de Enfermedades Infecciosas, 37007 Salamanca, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Salamanca, 37007 Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bezerra</LastName><ForeName>Joao F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Escola Tecnica de Sa&#xfa;de, Laboratorio de Vigilancia Molecular Aplicada, 68515-000 Par&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bezerra</LastName><ForeName>Marcos A C</ForeName><Initials>MAC</Initials><AffiliationInfo><Affiliation>Federal University of Pernambuco, Genetics Postgraduate Program, Recife 50670-907, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boix-Palop</LastName><ForeName>Luc&#xed;a</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital Universitario Mutua Terrassa, 08221 Terrassa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brion</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7463-2148</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de Santiago (IDIS), Xen&#xe9;tica Cardiovascular, 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brugada</LastName><ForeName>Ram&#xf3;n</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiovascular Genetics Center, Institut d'Investigaci&#xf3; Biom&#xe8;dica Girona (IDIBGI), 17190 Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Science Department, School of Medicine, University of Girona, 17190 Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Josep Trueta, Cardiology Service, 17190 Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bustos</LastName><ForeName>Matilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine of Seville (IBiS), Consejo Superior de Investigaciones Cient&#xed;ficas (CSIC)- University of Seville- Virgen del Rocio University Hospital, 41013 Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calder&#xf3;n</LastName><ForeName>Enrique J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-3166-5086</Identifier><AffiliationInfo><Affiliation>Departemento de Medicina, Hospital Universitario Virgen del Roc&#xed;o, Universidad de Sevilla, 41013 Seville, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Biomedicina de Sevilla, 41013 Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbonell</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Salamanca-IBSAL, Servicio de Medicina Interna, 37007 Salamanca, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Salamanca, 37007 Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castano</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Biocruces Bizkai HRI, 48903 Barakaldo, Bizkaia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Osakidetza, Cruces University Hospital, 48903 Barakaldo, Bizkaia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Diabetes and Metabolic Associated Diseases (CIBERDEM), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Pais Vasco, UPV/EHU, 48903 Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castelao</LastName><ForeName>Jose E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur, Xerencia de Xestion Integrada de Vigo-Servizo Galego de Sa&#xfa;de, 36312 Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conde-Vicente</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Universitario R&#xed;o Hortega, 47012 Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cordero-Lorenzana</LastName><ForeName>M Lourdes</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Servicio de Medicina intensiva, Complejo Hospitalario Universitario de A Coru&#xf1;a (CHUAC), Sistema Galego de Sa&#xfa;de (SERGAS), 15009 A Coru&#xf1;a, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortes-Sanchez</LastName><ForeName>Jose L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Tecnol&#xf3;gico de Monterrey, 64718 Monterrey, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Otto von Guericke University, Departament of Microgravity and Translational Regenerative Medicine, 39106 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corton</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Genetics &amp; Genomics, Instituto de Investigaci&#xf3;n Sanitaria-Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az University Hospital - Universidad Aut&#xf3;noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darnaude</LastName><ForeName>M Teresa</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Hospital Universitario Mostoles, Unidad de Gen&#xe9;tica, 28935 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Martino-Rodr&#xed;guez</LastName><ForeName>Alba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Aragon&#xe9;s de Ciencias de la Salud (IACS), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Investigaci&#xf3;n Sanitaria Arag&#xf3;n (IIS-Aragon), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Campo-P&#xe9;rez</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Preventive Medicine Department, Instituto de Investigacion Sanitaria Galicia Sur, Xerencia de Xestion Integrada de Vigo-Servizo Galego de Sa&#xfa;de, 36312 Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz de Bustamante</LastName><ForeName>Aranzazu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Universitario Mostoles, Unidad de Gen&#xe9;tica, 28935 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dom&#xed;nguez-Garrido</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unidad Diagn&#xf3;stico Molecular. Fundaci&#xf3;n Rioja Salud, 26006 La Rioja, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luchessi</LastName><ForeName>Andre D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Norte, Departamento de Analises Clinicas e Toxicologicas, 59012-570 Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eiros</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Salamanca-IBSAL, Servicio de Cardiolog&#xed;a, 37007 Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estigarribia Sanabria</LastName><ForeName>Gladys Mercedes</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Instituto Regional de Investigaci&#xf3;n en Salud-Universidad Nacional de Caaguaz&#xfa;, HH36+J3Q Caaguaz&#xfa;, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carmen Fari&#xf1;as</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IDIVAL, 39008 Cantabria, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Cantabria, 39008 Cantabria, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital U M Valdecilla, 39008 Cantabria, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Robelo</LastName><ForeName>Ux&#xed;a</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Urgencias Hospitalarias, Complejo Hospitalario Universitario de A Coru&#xf1;a (CHUAC), Sistema Galego de Sa&#xfa;de (SERGAS), 15009 A Coru&#xf1;a, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Rodr&#xed;guez</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unidad de Infecci&#xf3;n Viral e Inmunidad, Centro Nacional de Microbiolog&#xed;a (CNM), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Villa</LastName><ForeName>Tania</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Interacciones Gen-Ambiente y Salud (GIIGAS) - Instituto de Biomedicina (IBIOMED), Universidad de Le&#xf3;n, 24071 Le&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil-Fournier</LastName><ForeName>Bel&#xe9;n</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Getafe, Servicio de Gen&#xe9;tica, 28905 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Arrue</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto Aragon&#xe9;s de Ciencias de la Salud (IACS), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Investigaci&#xf3;n Sanitaria Arag&#xf3;n (IIS-Aragon), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez &#xc1;lvarez</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Instituto Aragon&#xe9;s de Ciencias de la Salud (IACS), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Investigaci&#xf3;n Sanitaria Arag&#xf3;n (IIS-Aragon), 50009 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez Bernaldo de Quir&#xf3;s</LastName><ForeName>Fernan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ministerio de Salud Ciudad de Buenos Aires, Buenos Aires C1425EFD CABA, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Pe&#xf1;as</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n (IiSGM), 28007 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Universidad Complutense, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Mental Health (CIBERSAM), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guti&#xe9;rrez-Bautista</LastName><ForeName>Juan F</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0003-1374-0756</Identifier><AffiliationInfo><Affiliation>Hospital Universitario Virgen de las Nieves, Servicio de An&#xe1;lisis Cl&#xed;nicos e Inmunolog&#xed;a, 18014 Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrero</LastName><ForeName>Mar&#xed;a Jos&#xe9;</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>IIS La Fe, Plataforma de Farmacogen&#xe9;tica, 46026 Valencia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Valencia, Departamento de Farmacolog&#xed;a, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrero-Gonzalez</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Data Analysis Department, Instituto de Investigaci&#xf3;n Sanitaria-Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az University Hospital - Universidad Aut&#xf3;noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez-Sousa</LastName><ForeName>Mar&#xed;a A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Unidad de Infecci&#xf3;n Viral e Inmunidad, Centro Nacional de Microbiolog&#xed;a (CNM), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lattig</LastName><ForeName>Mar&#xed;a Claudia</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Universidad de los Andes, Facultad de Ciencias, Bogot&#xe1; 111711, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SIGEN Alianza Universidad de los Andes - Fundaci&#xf3;n Santa Fe de Bogot&#xe1;, Bogot&#xe1; 111711, Clombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liger Borja</LastName><ForeName>Anabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital General de Segovia, Medicina Intensiva, 40002 Segovia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Rodriguez</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Genetics &amp; Genomics, Instituto de Investigaci&#xf3;n Sanitaria-Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az University Hospital - Universidad Aut&#xf3;noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancebo</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Universitario 12 de Octubre, Department of Immunology, 28041 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria Hospital 12 de Octubre (imas12), Transplant Immunology and Immunodeficiencies Group, 28041 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-L&#xf3;pez</LastName><ForeName>Caridad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital General de Segovia, Medicina Intensiva, 40002 Segovia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n</LastName><ForeName>Vicente</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Instituto de Biomedicina (IBIOMED), Universidad de Le&#xf3;n, 24071 Le&#xf3;n, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Nieto</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n Santa Fe de Bogota, Departamento Patologia y Laboratorios, Bogot&#xe1; 111711, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SIGEN Alianza Universidad de los Andes - Fundaci&#xf3;n Santa Fe de Bogot&#xe1;, Bogot&#xe1; 111711, Clombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Lopez</LastName><ForeName>Iciar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Unidad de Gen&#xe9;tica y Gen&#xf3;mica Islas Baleares, 07120 Islas Baleares, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario Son Espases, Unidad de Diagn&#xf3;stico Molecular y Gen&#xe9;tica Cl&#xed;nica, 07120 Islas Baleares, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Resendez</LastName><ForeName>Michel F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Tecnol&#xf3;gico de Monterrey, 64718 Monterrey, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Perez</LastName><ForeName>Angel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genomics of Complex Diseases Unit, Research Institute of Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzeu</LastName><ForeName>Juliana F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Faculdade de Medicina, Universidade de Bras&#xed;lia, Brasilia 70910-900, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o em Ci&#xea;ncias M&#xe9;dicas, Universidade de Bras&#xed;lia, Brasilia 70910-900, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o em Ci&#xea;ncias da Sa&#xfa;de, Universidade de Bras&#xed;lia, Brasilia 70910-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merayo Mac&#xed;as</LastName><ForeName>Eleuterio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital El Bierzo, Unidad Cuidados Intensivos, 24404 Le&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minguez</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Genetics &amp; Genomics, Instituto de Investigaci&#xf3;n Sanitaria-Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az University Hospital - Universidad Aut&#xf3;noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno Cuerda</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Universitario Mostoles, Medicina Interna, 28935 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Francisco de Vitoria, 28223 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silbiger</LastName><ForeName>Vivian N</ForeName><Initials>VN</Initials><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Norte, Departamento de Analises Clinicas e Toxicologicas, 59012-570 Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Silviene F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Faculdade de Medicina, Universidade de Bras&#xed;lia, Brasilia 70910-900, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o em Biologia Animal, Universidade de Bras&#xed;lia, Bras&#xed;lia 70910-900, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o Profissional em Ensino de Biologia, Universidade de Bras&#xed;lia, Bras&#xed;lia 70910-900, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o Profissional em Ensino de Biologia (UnB), Universidade de Bras&#xed;lia, Bras&#xed;lia 70910-900, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o em Ci&#xea;ncias M&#xe9;dicas, Universidade de Bras&#xed;lia, Bras&#xed;lia 70910-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortega-Paino</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Spanish National Cancer Research Center, CNIO Biobank, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parellada</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n (IiSGM), 28007 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Mental Health (CIBERSAM), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Universidad Complutense, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paz-Artal</LastName><ForeName>Estela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Universitario 12 de Octubre, Department of Immunology, 28041 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria Hospital 12 de Octubre (imas12), Transplant Immunology and Immunodeficiencies Group, 28041 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Complutense de Madrid, Department of Immunology, Ophthalmology and ENT, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Ney P C</ForeName><Initials>NPC</Initials><AffiliationInfo><Affiliation>Universidade Federal do Par&#xe1;, N&#xfa;cleo de Pesquisas em Oncologia, Bel&#xe9;m, Par&#xe1; 66075-110, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Matute</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Infectious Diseases, Microbiota and Metabolism Unit, Center for Biomedical Research of La Rioja (CIBIR), 26006 Logro&#xf1;o, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Inditex, 15141 A Coru&#xf1;a, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Tom&#xe1;s</LastName><ForeName>M Elena</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Instituto Murciano de Investigaci&#xf3;n Biosanitaria (IMIB-Arrixaca), 30120 Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perucho</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>GENYCA, 28220 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinsach-Abuin</LastName><ForeName>Mel Lina</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Cardiovascular Genetics Center, Institut d'Investigaci&#xf3; Biom&#xe8;dica Girona (IDIBGI), 17190 Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pompa-Mera</LastName><ForeName>Ericka N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social (IMSS), Centro M&#xe9;dico Nacional Siglo XXI, Unidad de Investigaci&#xf3;n M&#xe9;dica en Enfermedades Infecciosas y Parasitarias, Mexico City 02990, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porras-Hurtado</LastName><ForeName>Gloria L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Clinica Comfamiliar Risaralda, 660003 Pereira, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pujol</LastName><ForeName>Aurora</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bellvitge Biomedical Research Institute (IDIBELL), Neurometabolic Diseases Laboratory, 08908 L'Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Catalan Institution of Research and Advanced Studies (ICREA), 08010 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramiro Le&#xf3;n</LastName><ForeName>Soraya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Getafe, Servicio de Gen&#xe9;tica, 28905 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resino</LastName><ForeName>Salvador</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unidad de Infecci&#xf3;n Viral e Inmunidad, Centro Nacional de Microbiolog&#xed;a (CNM), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Marianne R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Universidade Federal do Par&#xe1;, N&#xfa;cleo de Pesquisas em Oncologia, Bel&#xe9;m, Par&#xe1; 66075-110, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Ophir Loyola, Departamento de Ensino e Pesquisa, Bel&#xe9;m, Par&#xe1; 66063-240, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Ruiz</LastName><ForeName>Emilio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unidad de Cuidados Intensivos, Hospital Cl&#xed;nico Universitario de Santiago (CHUS), Sistema Galego de Sa&#xfa;de (SERGAS), 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Artalejo</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, School of Medicine, Universidad Aut&#xf3;noma de Madrid, 28049 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IdiPaz (Instituto de Investigaci&#xf3;n Sanitaria Hospital Universitario La Paz), 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IMDEA-Food Institute, CEI UAM+CSIC, 28049 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Garcia</LastName><ForeName>Jos&#xe9; A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Complejo Asistencial Universitario de Le&#xf3;n, 24071 Le&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz Cabello</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital Universitario Virgen de las Nieves, Servicio de An&#xe1;lisis Cl&#xed;nicos e Inmunolog&#xed;a, 18014 Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada (ibs GRANADA), 18012 Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Granada, Departamento Bioqu&#xed;mica, Biolog&#xed;a Molecular e Inmunolog&#xed;a III, 18071 Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Hornillos</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Infanta Elena, Allergy Unit, Valdemoro, 28342 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria-Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az University Hospital - Universidad Aut&#xf3;noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Universidad Francisco de Vitoria, 28223 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Complutense University of Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gregorio Mara&#xf1;&#xf3;n Health Research Institute (IiSGM), 28007 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soria</LastName><ForeName>Jos&#xe9; Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Genomics of Complex Diseases Unit, Research Institute of Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souto</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Haemostasis and Thrombosis Unit, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamayo</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Clinico Universitario de Valladolid, Servicio de Anestesiologia y Reanimaci&#xf3;n, 47003 Valladolid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Valladolid, Departamento de Cirug&#xed;a, 47005 Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamayo-Velasco</LastName><ForeName>Alvaro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Clinico Universitario de Valladolid, Servicio de Hematologia y Hemoterapia, 47003 Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taracido-Fernandez</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Data Analysis Department, Instituto de Investigaci&#xf3;n Sanitaria-Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az University Hospital - Universidad Aut&#xf3;noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teper</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital de Ni&#xf1;os Ricardo Gutierrez, Buenos Aires C1425EFD CABA, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Tobar</LastName><ForeName>Lilian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n Universitaria de Ciencias de la Salud, 113827 Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urioste</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Spanish National Cancer Research Centre, Familial Cancer Clinical Unit, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valencia-Ramos</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital of Burgos, 09006 Burgos, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Y&#xe1;&#xf1;ez</LastName><ForeName>Zuleima</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Universidad Sim&#xf3;n Bol&#xed;var, Facultad de Ciencias de la Salud, 080002 Barranquilla, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarate</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro para el Desarrollo de la Investigaci&#xf3;n Cient&#xed;fica, 1255 Asunci&#xf3;n, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakanishi</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9510-5646</Identifier><AffiliationInfo><Affiliation>Institute for Molecular Medicine Finland (FIMM), 00014 Univerisity of Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGill University, Department of Human Genetics, H3A 0G4 Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lady Davis Institute, Jewish General Hospital, McGill University, H3T 1E2 Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyoto-McGill International Collaborative School in Genomic Medicine, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Fellow, Japan Society for the Promotion of Science, 102-0083 Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pigazzini</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Milano-Bicocca, 20126 Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Molecular Medicine Finland, Univerisity of Helsinki, 00014 Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Degenhardt</LastName><ForeName>Frauke</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7516-3179</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24118 Kiel, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital Schleswig-Holstein, Campus Kiel, 24118 Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler-Laporte</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5388-0396</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, H3A 0G4 Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lady Davis Institute, Jewish General Hospital, McGill University, H3T 1E2 Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maya-Miles</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Digestive Diseases Unit, Virgen del Rocio University Hospital, Institute of Biomedicine of Seville, University of Seville, 41103 Seville, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bujanda</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014 San Sebastian, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouysran</LastName><ForeName>Youssef</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Centre de G&#xe9;n&#xe9;tique Humaine, H&#xf4;pital Erasme, Universit&#xe9; Libre de Bruxelles, 1070 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palom</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Departament de Medicina, Bellatera, 08193 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vall d'Hebron Institut de Recerca (VHIR), Liver Diseases, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellinghaus</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Novo Nordisk Foundation Center for Protein Research, Disease Systems Biology, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24118 Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Bueno</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, 18016 Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolker</LastName><ForeName>Selina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Human Genetics, University Hospital Bonn, Medical Faculty University of Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amitrano</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Genetica Medica, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roade</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Departament de Medicina, Bellatera, 08193 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fava</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Siena, Medical Genetics, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azienda Ospedaliero-Universitaria Senese, Genetica Medica, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinner</LastName><ForeName>Christoph D</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0002-3875-5367</Identifier><AffiliationInfo><Affiliation>Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Department of Internal Medicine II, 80333 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prati</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Universit&#xe0; degli Studi di Milano, 20126 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardo</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mucosal Immunology Lab, Unidad de Excelencia del Instituto de Biomedicina y Gen&#xe9;tica Molecular (IBGM, Universidad de Valladolid-CSIC), 47005 Valladolid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital Universitario Clinico San Cecilio, 18016 Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Ibs, Granada, 18012 Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darcis</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Liege. GIGA-Insitute, B- 4000 Liege, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Liege University Hospital (CHU of Liege), B- 4000 Liege, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Cadenas</LastName><ForeName>Israel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Biomedical Research Institute Sant Pau (IIB Sant Pau), Stroke Pharmacogenomics and Genetics Group, 08041 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holter</LastName><ForeName>Jan Cato</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Oslo University Hospital, Department of Microbiology, 0424 Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, 0424 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banales</LastName><ForeName>Jesus M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, 20014 San Sebastian, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frithiof</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, 751 05 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duga</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Humanitas University, Department of Biomedical Sciences, 20089 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asselta</LastName><ForeName>Rosanna</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Humanitas University, Department of Biomedical Sciences, 20089 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Alexandre C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Heart Institute (InCor)/University of Sao Paulo Medical School, 05508-070 Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero-G&#xf3;mez</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Digestive Diseases Unit, Virgen del Rocio University Hospital, Institute of Biomedicine of Seville, University of Seville, 41103 Seville, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nafr&#xed;a-Jim&#xe9;nez</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Clinical Biochemistry Department, 20006 San Sebastian, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hov</LastName><ForeName>Johannes R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Norwegian PSC Research Center and Section of Gastroenterology, Dept Transplantation Medicine, Oslo University Hospital, 0424 Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, 0424 Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute of Internal Medicine, Oslo University Hospital, 0424 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Migeotte</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Fonds de la Recherche Scientifique (FNRS), B - 1000 Brussels.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de G&#xe9;n&#xe9;tique Humaine, H&#xf4;pital Erasme, Universit&#xe9; Libre de Bruxelles, 1070 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renieri</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3818-0871</Identifier><AffiliationInfo><Affiliation>University of Siena, Medical Genetics, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azienda Ospedaliero-Universitaria Senese, Genetica Medica, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Planas</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research of Barcelona (IIBB), National Spanish Research Council (CSIC), 08028 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludwig</LastName><ForeName>Kerstin U</ForeName><Initials>KU</Initials><Identifier Source="ORCID">0000-0002-8541-2519</Identifier><AffiliationInfo><Affiliation>Institute of Human Genetics, University Hospital Bonn, Medical Faculty University of Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buti</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Departament de Medicina, Bellatera, 08193 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahmouni</LastName><ForeName>Souad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Liege. GIGA-Insitute, B- 4000 Liege, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alarc&#xf3;n-Riquelme</LastName><ForeName>Marta E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, 18016 Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Environmental Medicine, Karolinska Institutet, 171 65 Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulte</LastName><ForeName>Eva C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Institute of Virology, Technical University Munich/Helmholtz Zentrum M&#xfc;nchen, D-85764 Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychiatric Phenomics and Genomics, University Hospital, LMU Munich University, 80539 Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University Hospital, LMU Munich University, 80539 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franke</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24118 Kiel, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital Schleswig-Holstein, Campus Kiel, 24118 Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlsen</LastName><ForeName>Tom H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Norwegian PSC Research Center and Section of Gastroenterology, Dept Transplantation Medicine, Oslo University Hospital, 0424 Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, 0424 Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute of Internal Medicine, Oslo University Hospital, 0318 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valenti</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universit&#xe0; degli Studi di Milano, Department of Pathopgysiology and Transplantation, 20126 Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transfusion Medicine and Hematology, Precision Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeberg</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Department of Neuroscience, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max-Planck Institute for Evolutionary Anthropology, 04103 Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Brent</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Epidemiology, Biostatistics and Occupational Health, McGill University, H3A 0G4 Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lady Davis Institute, Jewish General Hospital, McGill University, H3T 1E2 Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College London, Department of Twin Research, London, WC2R 2LS, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganna</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Molecular Medicine Finland, Univerisity of Helsinki, 00014 Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boada</LastName><ForeName>Merc&#xe8;</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Center and Memory clinic, ACE Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08028 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Rojas</LastName><ForeName>Itziar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Research Center and Memory clinic, ACE Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08028 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Agust&#xed;n</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Center and Memory clinic, ACE Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08028 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Juan</LastName><ForeName>Pascual</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CIEN Foundation/Queen Sofia Foundation Alzheimer Center, 28031 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Real</LastName><ForeName>Luis Miguel</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Valme, Unidad Cl&#xed;nica de Enfermedades Infecciosas y Microbiolog&#xed;a, 41014 Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>SCOURGE Cohort Group</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>HOSTAGE Cohort Group</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>GRA@CE Cohort Group</CollectiveName></Author><Author ValidYN="Y"><LastName>Guillen-Navarro</LastName><ForeName>Encarna</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Instituto Murciano de Investigaci&#xf3;n Biosanitaria (IMIB-Arrixaca), 30120 Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Secci&#xf3;n Gen&#xe9;tica M&#xe9;dica - Servicio de Pediatr&#xed;a, Hospital Cl&#xed;nico Universitario Virgen de la Arrixaca, Servicio Murciano de Salud, 30120 Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento Cirug&#xed;a, Pediatr&#xed;a, Obstetricia y Ginecolog&#xed;a, Facultad de Medicina, Universidad de Murcia (UMU), 30100 Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo Cl&#xed;nico Vinculado, Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayuso</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Genetics &amp; Genomics, Instituto de Investigaci&#xf3;n Sanitaria-Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az University Hospital - Universidad Aut&#xf3;noma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Neira</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Spanish National Cancer Research Centre, Human Genotyping-CEGEN Unit, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riancho</LastName><ForeName>Jos&#xe9; A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>IDIVAL, 39008 Cantabria, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Cantabria, 39008 Cantabria, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital U M Valdecilla, 39008 Cantabria, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-Martinez</LastName><ForeName>Augusto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3765-6778</Identifier><AffiliationInfo><Affiliation>Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, 64718 Monterrey, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genomics Division, Instituto Tecnol&#xf3;gico y de Energ&#xed;as Renovables, 38600 Santa Cruz de Tenerife, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit, Hospital Universitario N.S. de Candelaria, 38010 Santa Cruz de Tenerife, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Ciencias de la Salud, Universidad Fernando Pessoa Canarias, 35450 Las Palmas de Gran Canaria, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapunzina</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Gen&#xe9;tica M&#xe9;dica y Molecular (INGEMM), Hospital Universitario La Paz-IDIPAZ, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ERN-ITHACA-European Reference Network.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carracedo</LastName><ForeName>Angel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Nacional de Genotipado (CEGEN), Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Singular de Investigaci&#xf3;n en Medicina Molecular y Enfermedades Cr&#xf3;nicas (CIMUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n P&#xfa;blica Galega de Medicina Xen&#xf3;mica, Sistema Galego de Sa&#xfa;de (SERGAS), 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="Y">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="N">Sex Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056426" MajorTopicYN="N">Genetic Loci</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>16</Day><Hour>10</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35708486</ArticleId><ArticleId IdType="pmc">PMC9652109</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddac132</ArticleId><ArticleId IdType="pii">6607933</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tang, D., Komish, P. and Kang, R. (2020) The hallmarks of COVID-19 disease. PLoS Pathog., 16, e1008536. 10.1371/journal.ppat.1008536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008536</ArticleId><ArticleId IdType="pmc">PMC7244094</ArticleId><ArticleId IdType="pubmed">32442210</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal, P., Choi, J., Pinheiro, L., Schenck, E., Chen, R., Jabri, A., Satlin, M., Campion, R., Nahid, M., Ringel, J. &#xa0;et al. (2020) Clinical characteristics of Covid-19 in new York City. N. Engl. J. Med., 382, 2372&#x2013;2374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182018</ArticleId><ArticleId IdType="pubmed">32302078</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson, S., Hirsch, J., Narasimhan, M., Crawford, J., McGinn, T., Davidson, K. and the Northwell COVID-19 Research Consortium (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA, 323, 2052&#x2013;2059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahidy, F., Pan, A., Ahnstedt, H., Munshi, Y., Choi, H., Tiruneh, Y., Nasir, K., Kash, B., Andrieni, J. and McCullough, L. (2021) Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: cross-sectional analysis from a diverse US metropolitan area. PLoS One, 16, e0245556. 10.1371/journal.pone.0245556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245556</ArticleId><ArticleId IdType="pmc">PMC7806140</ArticleId><ArticleId IdType="pubmed">33439908</ArticleId></ArticleIdList></Reference><Reference><Citation>The COVID-19 Host Genetics Initiative (2020) The COVID-19 host genetics initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur. J. Hum. Genet., 28, 715&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220587</ArticleId><ArticleId IdType="pubmed">32404885</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova, C., Su, H. and COVID Human Genetic Effort (2020) A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection. Cell, 181, 1194&#x2013;1199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7218368</ArticleId><ArticleId IdType="pubmed">32405102</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira, E., Clohisey, S., Klaric, L., Bretherick, A., Rawlik, K., Pasko, D., Walker, S., Parkinson, N., Fourman, M., Russell, C. &#xa0;et al. (2021) Genetic mechanisms of critical illness in COVID-19. Nature, 591, 92&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33307546</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Q., Bastard, B., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I., Hodeib, S., Korol, C. &#xa0;et al. (2020) Inborn errors in type I IFN immunity in patients. Science, 370, eabd4570. 10.1126/science.abd4570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Host Genetics Initiative (2021) Mapping the human genetic architecture of COVID-19. Nature, 600, 472&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674144</ArticleId><ArticleId IdType="pubmed">34237774</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady, E., Nielsen, M., Andersen, J. and Oertelt-Prigione, S. (2021) Lack of consideration of sex and gender in COVID-19 clinical studies. Nat. Commun., 12, 4015. 10.1038/s41467-021-24265-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24265-8</ArticleId><ArticleId IdType="pmc">PMC8260641</ArticleId><ArticleId IdType="pubmed">34230477</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard, P., Rosen, L., Zhang, Q., Michailidis, E., Hoffmann, H., Dorgham, Z., Philippot, Q., Rosain, J., B&#xe9;ziat, V., Manry, J. &#xa0;et al. (2020) Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science, 370, eabd4570. 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlesworth, D. and Willis, H. (2009) The genetics of inbreeding depression. Nat. Rev. Genet., 10, 783&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">19834483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceballos, F., Joshi, P., Clark, D., Ramsay, M. and Wilson, J. (2018) Runs of homozygosity: windows into population history and trait architecture. Nat. Rev. Genet., 19, 220&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">29335644</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceballos, F., Hazelhurst, S., Clark, D., Agongo, G., Asiki, G., Boua, P., G&#xf3;mez-Oliv&#xe9;, X., Mashinya, F., Norris, S., Wilson, J. &#xa0;et al. (2020) Autozygosity influences cardiometabolic disease-associated traits in the AWI-gen sub-Saharan African study. Nat. Commun., 11, 5754. 10.1038/s41467-020-19595-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19595-y</ArticleId><ArticleId IdType="pmc">PMC7666169</ArticleId><ArticleId IdType="pubmed">33188201</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark, D., Okada, Y., Moore, K., Mason, D., Pirastu, N., Gandin, I., Mattsson, H., Barnes, C., Lin, K., Zhao, J. &#xa0;et al. (2019) Associations of autozygosity with a broad range of human phenotypes. Nat. Commun., 10, 4957. 10.1038/s41467-019-12283-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12283-6</ArticleId><ArticleId IdType="pmc">PMC6823371</ArticleId><ArticleId IdType="pubmed">31673082</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Grau, S., Fern&#xe1;ndez, M., de &#xa0;Rojas, I., Garcia-Gonz&#xe1;lez, P., Hern&#xe1;ndez, I., Farias, F., Budde, J., Quintela, I., Madrid, L., Gonz&#xe1;lez-P&#xe9;rez, A. &#xa0;et al. (2021) Long runs of homozygosity are associated with Alzheimer&#x2019;s disease. Transl. Psychiatry, 11, 142. 10.1038/s41398-020-01145-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-020-01145-1</ArticleId><ArticleId IdType="pmc">PMC7904832</ArticleId><ArticleId IdType="pubmed">33627629</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Grau, S., de &#xa0;Rojas, I., Hern&#xe1;ndez, I., Quintela, I., Montrreal, L., Alegret, M., Hern&#xe1;ndez-Olasagarre, B., Madrid, L., Gonz&#xe1;lez-Perez, A., Maro&#xf1;as, O. &#xa0;et al. (2019) Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ACE project. Alzheimers Dement., 15, 1333&#x2013;1347.</Citation><ArticleIdList><ArticleId IdType="pubmed">31473137</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard, P., Gervais, A., Le Voyer, T., Rosain, J., Philippot, Q., Manry, J., Michailidis, E., Hoffmann, H., Eto, S., Garcia-Prat, M. &#xa0;et al. (2021) Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci. Immunol., 6, EABL4340. 10.1126/sciimmunol.abl4340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4340</ArticleId><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>van der &#xa0;Made, C., Simons, A., Schuurs-Hoeijmakers, J., van den &#xa0;Heuvel, G., Mantere, T., Kersten, S., van &#xa0;Deuren, R., Steehouwer, M., van &#xa0;Reijmersdal, S., Jaeger, M. &#xa0;et al. (2020) Presence of genetic variants among young men with severe COVID-19. JAMA, 324, 663&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7382021</ArticleId><ArticleId IdType="pubmed">32706371</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallerini, C., Daga, S., Mantovani, S., Benetti, E., Picchiotti, N., Francisci, D., Paciosi, F., Schiaroli, E., Baldassarri, M., Fava, F. &#xa0;et al. (2021) Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study. Elife, 10, e67569. 10.7554/eLife.67569.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.67569</ArticleId><ArticleId IdType="pmc">PMC7987337</ArticleId><ArticleId IdType="pubmed">33650967</ArticleId></ArticleIdList></Reference><Reference><Citation>Asano, T., Boisson, B., Onodi, F., Matuozzo, D., Moncada-Velez, M., Maglorius Renkilaraj, M., Zhang, P., Meertens, L., Bolze, A., Materna, M. &#xa0;et al. (2021) X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci. Immunol., 6, eabl4348. 10.1126/sciimmunol.abl4348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4348</ArticleId><ArticleId IdType="pmc">PMC8532080</ArticleId><ArticleId IdType="pubmed">34413140</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe Covid-19 GWAS Group, Ellinghaus, D., Degenhardt, F., Bujanda, L., Buti, M., Albillos, A., Invernizzi, P., Fern&#xe1;ndez, J., Prati, D., Baselli, G. &#xa0;et al. (2020) Genomewide association study of severe Covid-19 with respiratory failure. N. Engl. J. Med., 383, 1522&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelton, J., Shastri, A., Ye, C., Weldon, C., Filshtein-Sonmez, T., Coker, D., Symons, A., Esparza-Gordillo, J., 23andMe COVID-19 Team, Aslibekyan, S. &#xa0;et al. (2021) Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat. Genet., 53, 801&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">33888907</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Bujanda, L., Bouysran, Y., Niemi, M., Palom, A. &#xa0;et al. (2021) Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J. Clin. Invest., 131, e152386. 10.1172/JCI152386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI152386</ArticleId><ArticleId IdType="pmc">PMC8631592</ArticleId><ArticleId IdType="pubmed">34597274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kousathanas, A., Pairo-Castineira, E., Rawlik, K., Stuckey, A., Odhams, C., Walker, S., Russell, C., Malinauskas, T., Millar, J., Elliott, K. &#xa0;et al. (2022) Whole genome sequencing reveals host factors underlying critival Covid-19. Nature. 10.1038/s41586-022-04576-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04576-6</ArticleId><ArticleId IdType="pmc">PMC9259496</ArticleId><ArticleId IdType="pubmed">35255492</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy, S., Saez, B., Mukhopadhyay, S., Ding, D., Ahmed, A., Chen, X., Pucci, F., Yamin, R., Wang, J., Pittet, M. &#xa0;et al. (2016) Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-&#x3ba;B inflammatory pathway. PNAS, 113, 1871&#x2013;1876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4763742</ArticleId><ArticleId IdType="pubmed">26831087</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon, D., Jang, G., Bouhaddou, M., Xu, J., Obernier, K., White, K., O'Meara, M., Rezelj, V., Guo, J., Swaney, D. &#xa0;et al. (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature, 583, 459&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>de &#xa0;Jong, T., Guryev, V. and Moshkin, Y. (2021) Estimates of gene ensemble noise highlight critical pathways and predict disease severity in H1N1, COVID-19 and mortality in sepsis patients. Sci. Rep., 11, 10793. 10.1038/s41598-021-90192-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90192-9</ArticleId><ArticleId IdType="pmc">PMC8144599</ArticleId><ArticleId IdType="pubmed">34031464</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins, J. and Rice, C. (2011) Interferon-stimulated genes and their antiviral effector functions. Curr. Op. Virol., 1, 519&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3274382</ArticleId><ArticleId IdType="pubmed">22328912</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski, K., Dudley, J., Kukurba, K., Chen, R., Butte, A., Montgomery, S. and Snyder, M. (2013) Systematic functional regulatory assessment of disease-associated variants. PNAS, 110, 9607&#x2013;9612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3677437</ArticleId><ArticleId IdType="pubmed">23690573</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaharuddin, S., Wang, V., Santos, R., Gross, A., Wang, Y., Jawanda, H., Zhang, Y., Hasan, W., Garcia, G., Jr., Arumugaswami, V. &#xa0;et al. (2021) Deleterious effects of SARS-CoV-2 infection on Human pancreatic cells. Front. Cell. Infect. Microbiol., 11, 678482. 10.3389/fcimb.2021.678482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.678482</ArticleId><ArticleId IdType="pmc">PMC8285288</ArticleId><ArticleId IdType="pubmed">34282405</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, R., Simoneau, C., Kulsuptrakul, J., Bouhaddou, M., Travisano, K., Hayashi, J., Carlson-Stevermer, J., Zengel, J., Richards, C., Fozouni, P. &#xa0;et al. (2021) Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses. Cell, 184, 106&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723770</ArticleId><ArticleId IdType="pubmed">33333024</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin, H., Kapoor, V., Kim, G., Li, P., Kim, H., Suresh, M., Kaech, S., Wherry, E., Selin, L., Leonard, W., Welsh, R.M. and Berg, L.J. (2017) Transient expression of ZBTB32 in anti-viral CD8+ T cells limits the magnitude of the effector response and the generation of memory. PLoS Pathog., 13, e1006544. 10.1371/journal.ppat.1006544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006544</ArticleId><ArticleId IdType="pmc">PMC5578684</ArticleId><ArticleId IdType="pubmed">28827827</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu, A., Zawislak, C., Nakayama, T. and Sun, J. (2014) The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nat. Immunol., 15, 546&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4404304</ArticleId><ArticleId IdType="pubmed">24747678</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, Y., Fukuda, N., Bai, C., Ma, T., Matthay, M. and Verkman, A. (2000) Role of aquaporins in alveolar fluid clearance in neonatal and adult lung, and in oedema formation following acute lung injury: studies in transgenic aquaporin null mice. J. Physiol., 525, 771&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2269974</ArticleId><ArticleId IdType="pubmed">10856128</ArticleId></ArticleIdList></Reference><Reference><Citation>Pires-Neto, R., Del Carlo Bernardi, F., Alves de Araujo, P., Mauad, T. and Dolhnikoff, M. (2016) The expression of water and ion channels in diffuse alveolar damage is not dependent on DAD Etiology. PLoS One, 11, e0166184. 10.1371/journal.pone.0166184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0166184</ArticleId><ArticleId IdType="pmc">PMC5106024</ArticleId><ArticleId IdType="pubmed">27835672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando, C., Suarez-Sipmann, F., Mellado-Artigas, R., Hern&#xe1;ndez, M., Gea, A., Arruti, E., Aldecoa, C., Mart&#xed;nez-Pall&#xed;, G., Mart&#xed;nez-Gonz&#xe1;lez, M., Slutsky, A. &#xa0;et al. (2020) Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med., 46, 2200&#x2013;2211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387884</ArticleId><ArticleId IdType="pubmed">32728965</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariajoseph-Antony, L.F., Kannan, A., Panneerselvam, A., Loganathan, C., Anbarasu, K. and Prahalathan, C. (2020) Aquaporin water channels and lung physiology. Am. J. Physiol. Lung Cell Mol., 278, L867&#x2013;L879.</Citation><ArticleIdList><ArticleId IdType="pubmed">10781416</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariajoseph-Antony, L., Kannan, A., Panneerselvam, A., Loganathan, C., Anbarasu, K. and Prahalathan, C. (2020) Could aquaporin modulators be employed as prospective drugs for COVID-19 related pulmonary comorbidity? &#xa0;Med. Hypotheses, 143, 110201. 10.1016/j.mehy.2020.110201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110201</ArticleId><ArticleId IdType="pmc">PMC7430244</ArticleId><ArticleId IdType="pubmed">33017909</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlesworth, B. (2001) Patterns of age-specific means and genetic variances of mortality rates predicted by the mutation-accumulation theory of ageing. J. Theor. Biol., 210, 47&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">11343430</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico, L., Benigni, A., Casiraghi, F., Ng, L., Renia, L. and Remuzzi, G. (2021) Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat. Rev. Nephrol., 17, 46&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7570423</ArticleId><ArticleId IdType="pubmed">33077917</ArticleId></ArticleIdList></Reference><Reference><Citation>Java, A., Apicelli, A., Liszewski, M., Coler-Reilly, A., Atkinson, J., Kim, A. and Kulkarni, H. (2020) The complement system in COVID-19: friend and foe? &#xa0;JCI Insight, 5, e140711. 10.1172/jci.insight.140711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140711</ArticleId><ArticleId IdType="pmc">PMC7455060</ArticleId><ArticleId IdType="pubmed">32554923</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo, M., Kemper, C. and Woodruff, T. (2020) COVID-19: complement, coagulation, and collateral damage. J. Inmunol., 205, 1488&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484432</ArticleId><ArticleId IdType="pubmed">32699160</ArticleId></ArticleIdList></Reference><Reference><Citation>Noris, M., Benigni, A. and Remuzzi, G. (2020) The case of complement activation in COVID-19 multiorgan impact. Kidney Int., 98, 314&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7246017</ArticleId><ArticleId IdType="pubmed">32461141</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn, E. and Connor, J. (2012) Chapter 9&#x2014;HijAkt: the PI3K/Akt pathway in virus replication and pathogenesis. Prog. Mol. Biol. Transl. Sci., 106, 223&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149925</ArticleId><ArticleId IdType="pubmed">22340720</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamy, P., R&#xe9;billard, X., Vacherot, F. and de la &#xa0;Taille, A. (2021) Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data. World J. Urol., 39, 3121&#x2013;3123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7266423</ArticleId><ArticleId IdType="pubmed">32488360</ArticleId></ArticleIdList></Reference><Reference><Citation>Wambier, C., Goren, A., Va&#xf1;o-Galv&#xe1;n, S., M&#xfc;ller, P., Ossimetha, A., Nau, G., Herrera, S. and McCoy, J. (2020) Androgen sensitivity gateway to COVID-19 disease severity. Drug Dev. Res., 81, 771&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273095</ArticleId><ArticleId IdType="pubmed">32412125</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang, D., Wang, L., Klionsky, D., Cheng, H. and Zhou, R. (2021) Sex differences in autophagy-mediated diseases: toward precision medicine. Autophagy, 17, 1065&#x2013;1076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8143224</ArticleId><ArticleId IdType="pubmed">32264724</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyce, A., Bai, Y., Nagpal, S. and Thompson, C. (2010) Research resource: the androgen receptor modulates expression of genes with critical roles in muscle development and function. Mol. Endocrinol., 24, 1665&#x2013;1674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5417449</ArticleId><ArticleId IdType="pubmed">20610535</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettoun, D., Scafonas, A., Rutledge, S., Hodor, P., Chen, O., Gambone, C., Vogel, R., McElwee-Witmer, S., Bai, C., Freedman, L. &#xa0;et al. (2005) Interaction between the androgen receptor and RNase L mediates a cross-talk between the interferon and androgen signaling pathways. J. Biol. Chem., 280, 38898&#x2013;38901.</Citation><ArticleIdList><ArticleId IdType="pubmed">16166078</ArticleId></ArticleIdList></Reference><Reference><Citation>Basrawala, Z., Alimirah, F., Xin, H., Mohideen, N., Campbell, S., Flanigan, R. and Choubey, D. (2006) Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells. Oncogene, 25, 2812&#x2013;2817.</Citation><ArticleIdList><ArticleId IdType="pubmed">16331249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, B., Ferguson, C., White, J., Wang, S., Vessella, R., True, L., Hood, L. and Nelson, P.S. (1999) Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res., 17, 4180&#x2013;4184.</Citation><ArticleIdList><ArticleId IdType="pubmed">10485450</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, Q., Li, W., Zhou, Q., Awasthi, P., Cazin, C., Yap, Y., Mladenovic-Lucas, L., Hu, B., Jeyasuria, P., Zhang, L. &#xa0;et al. (2021) Leucine zipper transcription factor-like 1 (LZTFL1), an intraflagellar transporter protein 27 (IFT27) associated protein, is required for normal sperm function and male fertility. Dev. Biol., 477, 164&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8277734</ArticleId><ArticleId IdType="pubmed">34023333</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldassarri, M., Picchiotti, N., Fava, F., Fallerini, C., Benetti, E., Daga, S., Valentino, F., Doddato, G., Furini, S., Giliberti, A. &#xa0;et al. (2021) Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males. EBioMedicine, 65, 103246. 10.1016/j.ebiom.2021.103246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103246</ArticleId><ArticleId IdType="pmc">PMC7908850</ArticleId><ArticleId IdType="pubmed">33647767</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris, P., Taylor, R., Thielke, R., Payne, J., Gonzalez, N. and Conde, J. (2009) Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform., 42, 377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris, P., Taylor, R., Minor, B., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J. &#xa0;et al. (2019) The REDCap consortium: building an international community of software partners. J. Biomed. Inform., 95, 103208. 10.1016/j.jbi.2019.103208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>The 1000 Genomes Project Consortium (2015) A global reference for human genetic variation. Nature, 526, 68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell, S., Ben, N., Todd-Brown, K., Thomas, L., Ferreira, M., Bender, D., Maller, J., Sklar, P., de &#xa0;Bakker, P., Daly, M. &#xa0;et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1950838</ArticleId><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Graffelman, J. and Moreno, V. (2013) The mid P-value in exact tests for hardy-Weinberg equilibrium. Stat. Appl. Genet. Mol. Biol., 12, 433&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pubmed">23934608</ArticleId></ArticleIdList></Reference><Reference><Citation>Price, A., Weale, M., Patterson, N., Myers, S., Need, A., Shianna, K., Ge, D., Rotter, J., Torres, E., Taylor, Q. &#xa0;et al. (2008) Long-range LD can confound genome scans in admixed populations. Am. J. Hum. Genet., 83, 132&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2443852</ArticleId><ArticleId IdType="pubmed">18606306</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander, D., Novembre, J. and Lange, K. (2009) Fast model-based estimation of ancestry in unrelated individuals. Genome Res., 19, 1655&#x2013;1664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752134</ArticleId><ArticleId IdType="pubmed">19648217</ArticleId></ArticleIdList></Reference><Reference><Citation>Taliun, D., Harris, D., Kessler, M., Carlson, J., Szpiech, Z., Torres, R., Galiano Taliun, S., Corvelo, A., Gogarten, S., Kang, H. &#xa0;et al. (2021) Sequencing of 53,831 diverse genomes from the NHLBI TOPMed program. Nature, 590, 290&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875770</ArticleId><ArticleId IdType="pubmed">33568819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, X., Levine, D., Shen, J., Gogarten, S., Laurie, C. and Weir, B. (2012) A high-performance computing toolset for relatedness and principal component analysis of SNP data. Bioinformatics, 28, 3326&#x2013;3328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3519454</ArticleId><ArticleId IdType="pubmed">23060615</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, X. and Davis, W. (2021) SAIGEgds&#x2014;an efficient statistical tool for large-scale PheWAS with mixed models. Bioinformatics, 37, 728&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pubmed">32898220</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, W., Nielsen, J., Fritsche, L., Dey, R., Gabrielsen, M., Wolford, B., LeFaive, J., VandeHaar, P., Gagliano, S., Figgord, A. &#xa0;et al. (2018) Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat. Genet., 50, 1335&#x2013;1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6119127</ArticleId><ArticleId IdType="pubmed">30104761</ArticleId></ArticleIdList></Reference><Reference><Citation>Willer, C., Li, Y. and Abecasis, G. (2010) METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics, 26, 2190&#x2013;2191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922887</ArticleId><ArticleId IdType="pubmed">20616382</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson, A., Watson, H. and Wallace, C. (2020) Improving the coverage of credible sets in Bayesian genetic fine-mapping. PLoS Comput. Biol., 16, e1007829. 10.1371/journal.pcbi.1007829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1007829</ArticleId><ArticleId IdType="pmc">PMC7179948</ArticleId><ArticleId IdType="pubmed">32282791</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, J., Lee, H., Goddard, E. and Visscher, P. (2011) GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet., 88, 76&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014363</ArticleId><ArticleId IdType="pubmed">21167468</ArticleId></ArticleIdList></Reference><Reference><Citation>Templeton, A. and Read, B. (1994) Inbreeding: one word, several meanings, much confusion. EXS, 68, 91&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">8032141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35357780</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2386-5857</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title><ISOAbbreviation>Emergencias</ISOAbbreviation></Journal><ArticleTitle>Current Spanish emergency department organization and clinical practicesin caring for patients with acute heart failure.</ArticleTitle><Pagination><StartPage>85</StartPage><EndPage>94</EndPage><MedlinePgn>85-94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.55633/s3me/E082.2022</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To describe routine diagnostic and therapeutic care processes and assignment of resources available for treating patients with acute heart failure (AHF) in Spanish hospital emergency departments (EDs).</AbstractText><AbstractText Label="MATERIAL AND METHODS">We surveyed the heads of all hospital EDs in the Spanish national health service concerning their routine diagnostic, therapeutic, and decision-making processes for treating patients with AHF. Questions also covered processes related to continuity of care for patients after discharge. Responses were grouped by hospital size and location (Spanish autonomous community) for comparison.</AbstractText><AbstractText Label="RESULTS">Heads of 250 of the 282 EDs (89%) responded. Thirty-two percent had a cardiologist on call, and a specialized AHF unit was present in 35%. Such untis were present in more than half the EDs in the Community of Madrid and in Catalonia. Eighty-four percent of EDs measured natriuretic peptide (NP) levels, 80% carried out echocardiographic assessments (although only 24% reported that more than half their staff were trained to undertake echocardiography), and 64% had high-flow nasal cannula (HFNC) systems. Only the Community of Valencia, Navarre, and La Rioja had the capacity for NP analysis, echocardiography, and HFNC therapy in 80% or more of their hospital EDs. Forty-six percent had admission protocols for patients with AHF, and 60% scheduled outpatient clinic appointments on discharge. Fifty-seven percent of the hospitals with AHF units had consensus-based protocols with their EDs, and 40% of them could schedule clinic appointments from the ED. Large hospitals had significantly better conditions with respect to some of these aspects of organization and care.</AbstractText><AbstractText Label="CONCLUSION">There is room for improvement in the diagnosis and treatment of patients with AHF. We detected opportunities to ensure more effective continuity of care for these patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mir&#xf3;</LastName><ForeName>&#xd2;scar</ForeName><Initials>&#xd2;</Initials><AffiliationInfo><Affiliation>&#xc1;rea de Urgencias, Hospital Cl&#xed;nic, Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Espa&#xf1;a. Facultad de Medicina y Ciencias de la Salud, Universitat de Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>&#xc1;rea de Urgencias, Hospital Cl&#xed;nic, Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>&#xc1;rea de Urgencias, Hospital Cl&#xed;nic, Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Repullo</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>&#xc1;rea de Urgencias, Hospital Cl&#xed;nic, Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Lamberechts</LastName><ForeName>Eric Jorge</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Cl&#xed;nico San Carlos, Instituto de Investigaci&#xf3;n Sanitaria del Hospital Cl&#xed;nico San Carlos (IDISSC), Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez Del Castillo</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Cl&#xed;nico San Carlos, Instituto de Investigaci&#xf3;n Sanitaria del Hospital Cl&#xed;nico San Carlos (IDISSC), Madrid, Espa&#xf1;a. Facultad de Medicina, Universidad Complutense de Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llorens</LastName><ForeName>Pere</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Unidad de Estancia Corta y Hospital a Domicilio, Hospital General d'Alacant. Instituto de Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de Alicante (ISABIAL), Alicante, Espa&#xf1;a. Facultad de Medicina, Universitat Miguel Hern&#xe1;ndez, Elx, Alacant, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Organizaci&#xf3;n y pr&#xe1;ctica cl&#xed;nica actual en los servicios de urgencias espa&#xf1;oles en la atenci&#xf3;n a los pacientes con insuficiencia cardiaca aguda.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Emergencias</MedlineTA><NlmUniqueID>9805751</NlmUniqueID><ISSNLinking>1137-6821</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Emergencias. 2022 Apr;34(2):81-82. doi: 10.55633/s3me/E080.2022.</RefSource><PMID Version="1">35275457</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013222" MajorTopicYN="Y">State Medicine</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO">Conocer la pr&#xe1;ctica cl&#xed;nica diagn&#xf3;stico-terap&#xe9;utica y de disposici&#xf3;n en los servicios de urgencias hospitalarios (SUH) espa&#xf1;oles en los pacientes con insuficiencia cardiaca aguda (ICA).</AbstractText><AbstractText Label="METODO">Encuesta a los responsables de todos los SUH p&#xfa;blicos espa&#xf1;oles sobre rutinas asistenciales diagn&#xf3;stico-terap&#xe9;uticas y de toma de decisi&#xf3;n en urgencias en la atenci&#xf3;n a pacientes con ICA. Se indagaron procesos relacionados con la continuidad asistencial de pacientes dados de alta. Los resultados se comparan seg&#xfa;n tama&#xf1;o del hospital y se detallan por comunidad aut&#xf3;noma.</AbstractText><AbstractText Label="RESULTADOS">Respondieron 250 de los 282 SUH espa&#xf1;oles (89%): 32% ten&#xed;an cardi&#xf3;logo de guardia y 35% unidad de insuficiencia cardiaca (UIC), presente en m&#xe1;s del 50% de hospitales de la Comunidad de Madrid y Catalu&#xf1;a. El 84% de SUH determina p&#xe9;ptidos natriur&#xe9;ticos (PN), 80% realiza evaluaci&#xf3;n ecogr&#xe1;fica (aunque solo el 24% tiene m&#xe1;s del 50% de sus facultativos formados) y el 64% dispone de c&#xe1;nulas nasales de alto flujo (CNAF). Solo la Comunidad Valenciana, Navarra y La Rioja disponen de PN, exploraci&#xf3;n ecogr&#xe1;fica y CNAF en $ 80% de sus SUH. El 46% tiene protocolizado d&#xf3;nde ingresar el paciente con ICA y el 60% dan cita ambulatoria. Un 57% de los hospitales con UIC tienen un protocolo consensuado con el SUH: el 40% puede asignar la citaci&#xf3;n desde urgencias. Los hospitales grandes muestran datos significativamente mejores en algunas de las caracter&#xed;sticas anteriormente mencionadas.</AbstractText><AbstractText Label="CONCLUSIONES">Existe margen de mejora en los SUH en cuanto a sus capacidades diagn&#xf3;stico-terap&#xe9;uticas de pacientes con ICA, y se detectan oportunidades para asegurar una continuidad asistencial m&#xe1;s efectiva.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AHF unit.</Keyword><Keyword MajorTopicYN="N">Acute heart failure (AHF).</Keyword><Keyword MajorTopicYN="N">Continuidad asistencial.</Keyword><Keyword MajorTopicYN="N">Continuity of patient care.</Keyword><Keyword MajorTopicYN="N">Diagnosis.</Keyword><Keyword MajorTopicYN="N">Diagn&#xf3;stico.</Keyword><Keyword MajorTopicYN="N">Emergency department.</Keyword><Keyword MajorTopicYN="N">Insuficiencia cardiaca aguda.</Keyword><Keyword MajorTopicYN="N">Unidad de insuficiencia cardiaca.</Keyword><Keyword MajorTopicYN="N">Urgencias.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>31</Day><Hour>12</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35357780</ArticleId><ArticleId IdType="doi">10.55633/s3me/E082.2022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34813190</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2386-5857</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title><ISOAbbreviation>Emergencias</ISOAbbreviation></Journal><ArticleTitle>Characteristics of isolated superficial vein thrombosis and diagnostictherapeutic management in Spanish hospital emergency departments: the ALTAMIRA study.</ArticleTitle><Pagination><StartPage>433</StartPage><EndPage>440</EndPage><MedlinePgn>433-440</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To describe the characteristics of patients with isolated lower-limb superficial vein thrombosis (SVT) treated in hospital emergency departments and to evaluate adherence to clinical practice guidelines on diagnosis (vein ultrasound imaging) and therapeutic management (start of anticoagulant therapy).</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Retrospective cohort study in 18 Spanish emergency departments. We included all patients with a final emergency department diagnosis of lower-limb SVT aged 18 years or older between January 2016 and May 2017. Backward stepwise multiple logistic regression analysis was used to evaluate adherence to clinical practice guidelines on ordering vein ultrasound imaging and starting anticoagulant therapy.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1166 patients were included. The mean patient age was 59.6 years, and 67.9% were women. About a quarter of the patients (24.4%) had a history of venous thromboembolic disease. Complications developed in 8.9% within 180 days: 4.6% experienced a recurrence and 3.6% progressed to SVT and 1.8% to deep vein thrombosis; pulmonary thromboembolism occurred in 0.9%. Hemorrhagic complications developed in 17 patients (1.5%). Sixteen patients (1.4%) died. Vein ultrasound imagine was ordered for 703 patients (60.3%). Anticoagulant agents were prescribed for 898 (77%) for a median period of 22 days. Variables associated with a decision to order anticoagulants were a history of venous thromboembolic disease (odds ratio [OR], 1.60; 95% CI, 1.12-2.30), varicose veins (OR, 1.40; 95% CI, 1.12-2.30); limb pain (OR, 1.44; 95% CI, 1.08-1.91); painful cord (OR, 1.30; 95% CI, 0.97-1.73); and availability of vein ultrasound images (OR, 1.60; 95% CI, 1.94-3.45).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Adherence to clinical practice guidelines for the diagnosis and treatment of isolated lower-limb SVT is low in Spanish emergency departments. Ultrasound imaging is not ordered for 1 out of every 2 to 3 patients, and anticoagulant treatment is not started in 1 out of 4 patients. There is great room for improvement.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beddar Chaib</LastName><ForeName>Fahd</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Complejo Asistencial de Soria, Espa&#xf1;a. Universidad de Valladolid, Facultad de Ciencias de la Salud, Valladolid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez Hern&#xe1;ndez</LastName><ForeName>S&#xf2;nia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>&#xc1;rea de Urgencias, Hospital Clinic, IDIBAPS, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedrajas Navas</LastName><ForeName>Jos&#xe9; Mar&#xed;a</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carriel Mancilla</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Gastro Obeso Center, Guayaquil, Ecuador. Facultad de Ciencias M&#xe9;dicas, Universidad Cat&#xf3;lica De Santiago de Guayaquil, Ecuador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro Arias</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Doce de Octubre, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merlo Loranca</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario de Getafe, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peir&#xf3; G&#xf3;mez</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Arnau de Vilanova-Lliria, Valencia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez M&#xe1;rquez</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Nuestra Se&#xf1;ora de Valme, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lozano Polo</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital de la Santa Creu i Sant Pau, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez Garrido-Lestache</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital General de Albacete, Albacete, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lecumberri</LastName><ForeName>Ram&#xf3;n</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Hematolog&#xed;a, Cl&#xed;nica Universidad de Navarra, Pamplona, Navarra, Espa&#xf1;a. CIBER-CV, Pamplona, Navarra, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz Artacho</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Departamento de Medicina Interna, Cl&#xed;nica Universidad de Navarra, Madrid, Espa&#xf1;a. CIBER de Enfermedades Respiratorias, CIBERES, Madrid, Espa&#xf1;a. Interdisciplinar Teragnosis and Radiosomics (INTRA) Research Group, Universidad de Navarra, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Grupo de Enfermedad Tromboemb&#xf3;lica Venosa de la Sociedad Espa&#xf1;ola de Medicina de Urgencias y Emergencias (ETV-SEMES)</CollectiveName></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><VernacularTitle>Caracter&#xed;sticas y manejo diagn&#xf3;stico-terap&#xe9;utico de los pacientes con trombosis venosa superficial aislada en los servicios de urgencias hospitalarios espa&#xf1;oles. Estudio ALTAMIRA.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Emergencias</MedlineTA><NlmUniqueID>9805751</NlmUniqueID><ISSNLinking>1137-6821</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Describir las caracter&#xed;sticas de los pacientes diagnosticados de trombosis venosa superficial (TVS) aislada de miembros inferiores en servicios de urgencias hospitalarios (SUH), y evaluar la adherencia a las gu&#xed;as de pr&#xe1;ctica cl&#xed;nica en el manejo diagn&#xf3;stico y terap&#xe9;utico (realizaci&#xf3;n de ecograf&#xed;a venosa e instauraci&#xf3;n de tratamiento anticoagulante).</AbstractText><AbstractText Label="METODO" NlmCategory="METHODS">. Estudio de cohortes retrospectivo en 18 SUH espa&#xf1;oles. Se incluyeron todos los pacientes atendidos en los SUH con diagn&#xf3;stico final de TVS en miembros inferiores, con edad $ 18 a&#xf1;os, de enero de 2016 a mayo de 2017. Para evaluar la no adherencia a las recomendaciones de las gu&#xed;as de pr&#xe1;ctica cl&#xed;nica (realizaci&#xf3;n de ecograf&#xed;a venosa, e instauraci&#xf3;n de tratamiento anticoagulante) se ajust&#xf3; un modelo de regresi&#xf3;n log&#xed;stica m&#xfa;ltiple por pasos hacia atr&#xe1;s.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">. Mil ciento sesenta y seis pacientes fueron incluidos. La edad media fue de 59,6 a&#xf1;os, el 67,9% eran mujeres. El 24,4% ten&#xed;an antecedentes de enfermedad tromboemb&#xf3;lica venosa (ETV). El 8,9% tuvieron alguna complicaci&#xf3;n a 180 d&#xed;as [4,6% recurrencia y 3,6% progresi&#xf3;n de TVS, 1,8% trombosis venosa profunda (TVP) y 0,9% tromboembolia pulmonar (TEP)]. Hubo 17 pacientes (1,5%) con hemorragia y 16 (1,4%) muertes. Se realiz&#xf3; ecograf&#xed;a venosa a 703 (60,3%) pacientes. Recibieron tratamiento anticoagulante 898 (77%), con una mediana de 22 d&#xed;as. Las variables asociadas con la decisi&#xf3;n de anticoagular fueron: antecedentes ETV (OR 1,60; IC 95%: 1,12-2,30), varices (OR 1,40; IC 95%: 1,12-2,30), dolor de la extremidad (OR 1,44; IC 95%: 1,08-191), presencia de cord&#xf3;n doloroso (OR 1,30; IC 95%: 0,97-1,73) y realizaci&#xf3;n de ecograf&#xed;a venosa (OR 1,60; IC 95%: 1,94-3,45).</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">Existe una baja adherencia a las recomendaciones de las gu&#xed;as de pr&#xe1;ctica cl&#xed;nica en el manejo diagn&#xf3;stico y terap&#xe9;utico de los pacientes con diagn&#xf3;stico de TVS aislada de miembros inferiores en los SUH espa&#xf1;oles: no se realiza ecograf&#xed;a venosa en uno de cada 2-3 pacientes, y no se instaura tratamiento anticoagulante en 1 de cada 4. Esto constituye un margen de mejora muy relevante.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Emergency department.</Keyword><Keyword MajorTopicYN="Y">Enfermedad tromboemb&#xf3;lica venosa.</Keyword><Keyword MajorTopicYN="Y">Thromboembolic disease.</Keyword><Keyword MajorTopicYN="Y">Trombosis venosa superficial.</Keyword><Keyword MajorTopicYN="Y">Urgencias.</Keyword><Keyword MajorTopicYN="Y">Venous thrombosis, superficial.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>23</Day><Hour>12</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34813190</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">33268106</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5808</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Neurologia</Title><ISOAbbreviation>Neurologia (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Study about the Manchester Triage System subtriage in patients that visited the Emergency Department due to headache.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0213-4853(20)30275-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nrl.2020.06.019</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Headache is a frequent cause of consultation; it is important to detect patients with secondary headache, particularly high-risk secondary headache. Such systems as the Manchester Triage System (MTS) are used for this purpose. This study aims to evaluate the frequency of sub-triage in patients attending the Emergency Department due to headache.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">We studied a series of consecutive patients who came to the Emergency Department with headache and presenting some warning sign, defined as the presence of signs leading the physician to request an emergency neuroimaging study and/or assessment by the on-call neurologist. The reference diagnosis was established by neurologists. We evaluated the MTS triage level assigned and the presence of warning signs that may imply a higher level than that assigned.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We registered a total of 1,120 emergency department visits due to headache, and 248 patients (22.8%) were eligible for study inclusion. Secondary headache was diagnosed in 126 cases (50.8% of the sample; 11.2% of the total), with 60 cases presenting high-risk secondary headache (24.2%; 5.4%). According to the MTS, two patients were classified as immediate (0.8%), 26 as very urgent (10.5%), 147 as urgent (59.3%), 68 as normal (27.4%), and five as not urgent (2%). The percentage of patients under-triaged was 85.1% in the very urgent classification level and 23.3% in the urgent level.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">During the study period, at least one in 10 patients attending the Emergency Department due to headache had secondary headache; one in 20 had high-risk secondary headache. The MTS under-triaged most patients with warning signs suggesting a potential emergency.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Sociedad Espa&#xf1;ola de Neurolog&#xed;a. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garc&#xed;a-Azor&#xed;n</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas, Servicio de Neurolog&#xed;a, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Espa&#xf1;a; Instituto de Investigaci&#xf3;n Biom&#xe9;dica de Salamanca (IBSAL), Salamanca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abelaira-Freire</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Emergencias, Hospital Cl&#xed;nico Universitario San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Adrada</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Emergencias, Hospital Rey Juan Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Garc&#xed;a</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas, Servicio de Neurolog&#xed;a, Hospital Cl&#xed;nico Universitario San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerrero</LastName><ForeName>&#xc1; L</ForeName><Initials>&#xc1;L</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas, Servicio de Neurolog&#xed;a, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Espa&#xf1;a; Instituto de Investigaci&#xf3;n Biom&#xe9;dica de Salamanca (IBSAL), Salamanca, Espa&#xf1;a; Departamento de Medicina, Facultad de Medicina, Universidad de Valladolid, Valladolid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porta-Etessam</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas, Servicio de Neurolog&#xed;a, Hospital Cl&#xed;nico Universitario San Carlos, Madrid, Espa&#xf1;a; Instituto de Investigaci&#xf3;n Sanitaria San Carlos (IdISSC), Madrid, Espa&#xf1;a. Electronic address: jporta@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-S&#xe1;nchez</LastName><ForeName>F J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Servicio de Emergencias, Hospital Cl&#xed;nico Universitario San Carlos, Madrid, Espa&#xf1;a; Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Espa&#xf1;a; Instituto de Investigaci&#xf3;n Sanitaria San Carlos (IdISSC), Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Estudio sobre el subtriaje del Sistema de Triaje de Manchester en pacientes que acuden a Urgencias por cefalea.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Neurologia (Engl Ed)</MedlineTA><NlmUniqueID>101778590</NlmUniqueID><ISSNLinking>2173-5808</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cefaleas</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Diagn&#xf3;stico</Keyword><Keyword MajorTopicYN="N">Emergencias</Keyword><Keyword MajorTopicYN="N">Emergency medicine</Keyword><Keyword MajorTopicYN="N">Headache disorders</Keyword><Keyword MajorTopicYN="N">Triage</Keyword><Keyword MajorTopicYN="N">Triaje</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33268106</ArticleId><ArticleId IdType="doi">10.1016/j.nrl.2020.06.019</ArticleId><ArticleId IdType="pii">S0213-4853(20)30275-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>